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PROMOTING LIFE?: EMBRYONIC STEM CELL
RESEARCH LEGISLATION
J. Frederick Miller, Jr.'
Archbishop Trench once commented that "the road to hell is paved
with good intentions."' In other words, sometimes we want to achieve
what we believe to be an honorable goal, but in so doing we
inadvertently commit a grave transgression.2 In no other present political
context does this adage fit more readily than the current debate over
federal funding for embryonic stem cell (ESC) research Both
supporters and opponents of federal funding for ESC research want to
achieve what they believe is a greater good, yet politicians, patients,
scientists, religious leaders, and voting citizens are torn between the
promise of advances in medical research and the ongoing ethical
dilemma of when life begins.4 For both sides, the ultimate end of this
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1. BURTON STEVENSON, THE HOME BOOK OF QUOTATIONS 891 (1952). This
adage finds biblical support in Romans 3:7-8, which states: "But if God's truth redounds to
his glory, through my falsehood, why am I still being condemned as a sinner? And why
not say - as we are accused and as some claim we say - that we should do evil that good
may come of it?" Romans 3:7-8 (The New American Bible, Saint Joseph Edition).
Building on this verse from Romans, in his papal encyclical Humanae Vitae, Pope Paul VI
claims that "it is not licit ... to make into the object of a positive act of the will something
which is intrinsically disorder, and hence unworthy of the human person, even when the
intention is to safeguard or promote individual, family or social well-being." Paul VI,
Humanae Vitae ("Of Human Life") T 14 (1968) [hereinafter Humanae Vitae]. Please note
that papal encyclicals are cited by paragraph rather than page number.
2. See, e.g., CATECHISM OF THE CATHOLIC CHURCH 1799-1801 (United States
Catholic Conference, Inc. trans., 1994) [hereinafter CATECHISM] (clarifying the Catholic
belief that human beings must follow their consciences in making decisions and in judging
rightly or erroneously). Like papal encyclicals, it is proper to cite the CATECHISM by
paragraph rather than page number.
3. See Fr. Vincent Fitzpatrick, President Makes Tragic Blunder, COMMUNIQUIE
(Sept. 14, 2001), available at http://www.all.org/communique/cq010914.htm (last visited
Nov. 14, 2001) (stating that the use of the adage is fitting for President Bush's decision and
embryonic stem cell research in general because it is "utilitarian" and "consequentialist").
4. See Laurie McGinley & Anne Fawcett, Patients and Abortion Foes Clash on
Stem-Cell Research, WALL ST. J., June 21, 1999, at A28; see also Bob Davis, Put to the Test:
GOP Avoids Abortion for Now, But Science Is Stirring the Debate, WALL ST. J., Aug. 1,
2000, at Al.
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debate is to improve the human condition and save lives.5 However, the
difference lies in identifying whose lives are to be saved and the best
means of doing so.6
On one side of the ESC debate, some argue that ESC research will
improve or save the lives of already born individuals who suffer from
terrible diseases.7 Others contend that because the extraction of stem
cells from an embryo destroys the embryo, such research is morally
tainted.8 The response of ESC research proponents is to use only those
ESCs derived from in vitro fertilization (IVF) clinic embryos, which are
already destined to be discarded.9 In essence, proponents believe that
5. Compare Hearing on Stem Cell Ethical Issues and Intellectual Property Rights
Before the Senate Appropriations Subcomrr on Labor, Health and Human Services, Educ.
and Related Agencies, 107th Cong. (2001) [hereinafter Aug. 2001 Hearings] (statement of
Senator Arlen Specter (R-PA)) (expressing his belief that there is no issue more
important than ESC research because of its potential to cure millions of people and
offering that justification for introducing Senate Bill S. 723), and Hearing on Stem Cell
Ethical Issues and Intellectual Property Rights Before the Senate Appropriations Subcomm.
on Labor, Health and Human Services, Educ. and Related Agencies, 107th Cong. (2001)
[hereinafter July 2001 Hearings] (statement of Senator Tom Harkin (D-IA)) (describing
the reason why he co-sponsored S. 723 with Senator Specter as a way "to save lives and
find cures for some of the most debilitating diseases"), with Remarks by the President on
Stem Cell Research, Televised Address (Aug. 9, 2001), available at http://www.
whitehouse.gov/news/releases/2001/08/print/20010809-2.htm (last visited Sept. 2, 2001)
[hereinafter Bush Proposal] (allowing research on limited ESC lines that have been
extracted prior to the President's decision because President Bush wanted to "explore the
promise and potential of stem cell research without crossing a fundamental moral line"),
and S. 1349, 107th Cong. § 2 (2001) (finding that ESC research "based on ethically
responsible stem cell sources may lead to exponential improvements in the treatment of
many terminal and debilitating conditions").
6. Compare Bush Proposal, supra note 5, and S. 723, 107th Cong. (2001) (allowing
ESCs to help individuals with diseases like Parkinson's, Alzheimer's, and diabetes but at
the expense of the embryo's life), with S. 1349, 107th Cong. (2001) (forbidding embryo
destruction, thereby saving lives; promoting the use of those stem cells that are already
treating numerous diseases; and establishing a nationwide donor bank to ensure proper
genetic matches for patients).
7. See Rick Weiss, U.S. To Issue New Rules for Research on Embryo Cells, WASH.
POST, Aug. 23, 2000, at Al. For example, Daniel Perry, Chairman of the Patients'
Coalition for Urgent Research, stated: 'What the patient groups have been saying all
along is, 'Get on with it. We want this for our loved ones."' Id.
8. July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger, Associate
Director for Policy Development at the Secretariat for Pro-Life Activities) (stating that
"obtaining and destroying embryos is an integral part of this project"); see also Robert P.
George, Don't Destroy Human Life, WALL ST. J., July 30,2001, at A18.
9. Hearing on Embryonic Stem Cell Research Before the House Subcomm. on
Criminal Justice, Drug Policy and Human Resources, 107th Cong. (2001) [hereinafter July
2001 Criminal Justice Hearings] (testimony of Senator Orrin Hatch (R-Utah). In
reference to his precarious situation of opposing abortion yet supporting ESC research,
Senator Hatch queries, "Why shouldn't these embryos slated for destruction [in IVF
clinics] be used for the good of mankind?" Id.; see also Rick Weiss, Embryo Research is
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instead of discarding the embryos, scientists should use them to derive
ESCs for research because they have a great deal of scientific promise."0
Opponents of the research do not share this form of biological
utilitarianism because they believe that human life deserves respect at all
stages of development. They believe that justifying an embryo's
destruction with the argument that another person may be saved is an
affront to human dignity. They look to protect unborn life, in the form
of human embryos, from destruction while they support alternative
measures of stem cell research to treat diseases. 2
One of the more vocal opponents of ESC research is the Catholic
Church (Church). 3 The Church deems that from the moment of
Backed; Ethicists See Benefits Overriding Qualms, WASH. POST, May 23, 1999, at Al
(quoting a statement from the National Bioethics Advisory Commission (NBAC) that
"[c]onservatives who accept that killing a fetus is permissible where it is necessary to save
the life of the mother should agree with liberals that it is also permissible to destroy
embryos where it is necessary to save people").
10. McGinley & Fawcett, supra note 4 (outlining both sides of the debate and
focusing on the issue of using IVF embryos to extract ESCs for research).
11. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(attacking the argument that embryos "would be discarded anyway" by analogizing the
situation to killing the terminally ill or death row inmates to harvest their vital organs
because they are slated for death).
12. It is vital to a discussion of this issue to understand the difference between the
terms "stem cell" and "embryonic stem cell." See THE NAT'L BIOETHICS ADVISORY
COMM'N, ETHICAL ISSUES IN HUMAN STEM CELL RESEARCH: REPORT AND
RECOMMENDATIONS OF THE NATIONAL BIOETHICS ADVISORY COMMISSION 7-8 (1999)
[hereinafter NBAC REPORT AND RECOMMENDATIONS]. "Stem cell" is a comprehensive
term that refers to numerous forms of stem cells, including embryonic stem cells, adult
stem cells, umbilical cord blood stem cells, and placental stem cells. See id. Therefore, all
embryonic stem cells are stem cells, yet not all stem cells are embryonic. See id. For a
thorough explanation of the scientific terms involved in the ESC debate, see infra Part
II.A. For a discussion of the widespread misconception that overwhelming support for
stem cell research invariably means support for embryonic stem cell research, see United
States Conference of Catholic Bishops, Stem Cell Reality Check #2, available at http://
www.nccbuscc.org/prolife/issues/bioethic/stemfax2.htm (last visited Sept. 26, 2001)
[hereinafter Reality Check #2].
13. The District of Columbia is home to the headquarters of the United States
Conference of Catholic Bishops, whose office of the Secretariat for Pro-Life Activities
sent Richard M. Doerflinger to testify before Congress on numerous occasions regarding
the issue of federal funding for ESC research. See, e.g., Hearing on Legal Status of
Embryonic Stem Cell Research Before the Senate Appropriations Subcomm on Labor,
Health and Educ., 106th Cong. (1999) [hereinafter Jan. 1999 Hearings] (testimony of
Richard M. Doerflinger, Associate Director for Policy Development at the Secretariat for
Pro-Life Activities); July 2001 Hearings, supra note 5 (testimony of Richard M.
Doerflinger, Associate Director for Policy Development at the Secretariat for Pro-Life
Activities).
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conception, human life must be protected. 4  Beginning with this tenet,
Catholic opponents of ESC research believe that any action that
intentionally destroys a human embryo cannot be justified under any
circumstance.15 Moreover, the Church supports other promising forms of
stem cell research, which not only protect the sanctity of life, but also
hold the promise of advancing medical treatment for a broader segment
of society.'
The goal of this Comment is to evaluate and understand how, through
the lens of Catholic social teaching, recent legislation and the President's
proposal concerning federal funding of stem cell research is indicative of
American society's progression toward a "Culture of Death."'7 This
Comment is not intended to create further division among the already
polarized sides of the ESC research debate; rather, its purpose is to
demonstrate that if one starts with the basic principle that life begins at
conception, one cannot accept ESC research as a legitimate pursuit of
federal law." Regardless of whether it is conducted with the ultimateintent of saving lives or improving the quality of life for those suffering
14. See CATECHISM, supra note 2, 2270. Biblical references to human life
beginning at conception are found in Jeremiah 1:5 and Psalms 22:10-11, 139:14-15.
Jeremiah 1:5 is the most popular of the biblical verses, often found on pro-life bumper
stickers and tee shirts. It reads: "Before I formed you in the womb I knew you." Jeremiah
1:5.
15. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(claiming that "[t]he intrinsic wrong of destroying innocent human life cannot be
'outweighed' by any material advantage - in other words, the end does not justify an
immoral means"); see also Rick Weiss, A Look at Science and Religion; On Ethics and
Embryo Research, WASH. POST, June 13, 1999, at B3 (providing excerpts from the
testimony of various religious leaders before the NBAC concerning federal funding for
ESC research).
16. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(listing the numerous alternative stem cells that have been successfully used to treat
patients with spinal cord injuries, juvenile diabetes, cancer, and leukemia, among others).
17. In his papal encyclical, Evangelium Vitae, Pope John Paul II defines the "Culture
of Death" as a "structure of sin" that denies solidarity and is "fostered by powerful
cultural, economic, and political currents that encourage an idea of society excessively
concerned with efficiency;" it constitutes "a war of the powerful against the weak" where a
"conspiracy against life is unleashed." John Paul II, Evangelium Vitae ("The Gospel of
Life") 12, in THE ENCYCLICALS OF JOHN PAUL II 682, 690 (J. Michael Miller ed., 2001)
[hereinafter Evangelium Vitae].
1& See Arthur Allen, God and Science, WASH. POST, Oct. 15, 2000, at W8 ("For
those who think an embryo is a life, .. . stem cell research offers no justification for killing
it other than research whose benefit is no more certain than the embryo's humanity.").
But see July 2001 Hearings, supra note 5 (statement of Senator Tom Harkin (D-IA))
("The government has an important role to play in supporting basic science. Basic science
will always be underfunded by the private sector.... ").
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from diseases such as diabetes, Alzheimer's, or Parkinson's, ESC
research requires the destruction of a human embryo - an act that is
unnecessary in light of other scientific alternatives."
Part I of this Comment explains the development of the use of stem
cell research. Part II examines the ethical debate surrounding the
medical use of stem cells, which has propelled the issue to the forefront
of American political life. Part III of this Comment outlines three
proposed solutions for "ethically"' funding ESC research with federal
money, and Part IV queries whether ESC research is necessary. This
Comment then explains the extent to which each proposal promotes
either the Culture of Death or the Gospel of Life, as defined by Pope
John Paul II in Evangelium Vitae." The focus of this Comment then
turns to each proposal's ramifications for the ESC research debate.
Finally, Part V of this Comment discusses why it is important for
individuals who respect life to reflect upon whether federal funding for
ESC research is necessary to achieve its desired end.
I. BACKGROUND: THE PATH TO THE PRESENT
A. The Development of Embryo Research and the Accompanying
Political Drama
Although researchers successfully isolated ESCs in 1998,2 ESCs
themselves - and the political issues surrounding them - find their roots
in the IVF controversy of the late 1970s. 3 During the late 1970s,24 Patrick
19. July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (stating that
ESC research supported with federal funding is "illegal, unethical, and unnecessary"
because "[rlesearch using stem cells not derived from human embryos has confirmed...
that adult stem cells.., have vast biomedical potential to cure diseases... [that is] as great
as or greater than the potential offered by human embryonic stem cell[s]").
20. See Rick Weiss, Panel Drafts Ethics Plan for Embryo Cell Studies; Rules Would
Guide Federally Funded Research, WASH. POST, Apr. 9, 1999, at A2. The word "ethically"
is placed in quotations because the idea of obtaining and performing research on embryo
cells "ethically" has been viewed by some as oxymoronic. Id.
21. See Evangelium Vitae, supra note 17, 1.1, 12.
22 See Robert Langreth, Labs Make Major Advance in Biotechnology, WALL ST. J.,
Nov. 6, 1998, at A3 (announcing the successful isolation of human stem cells by James
Thomson at the University of Wisconsin and John Gearhart at Johns Hopkins University).
23. See Ronald M. Green, Stopping Embryo Research, 9 HEALTH MATRIX 235, 237
(1999) (observing that "embryo research is very much a consequence of the development
of the technology of in vitro fertilization..
24. Id.
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Steptoe, Robert Edwards, and others developed IVF technology, the
process by which infertile couples create embryos in the laboratory for
implantation.2 Essentially, these scientists stimulated ovaries to increase
egg production, removed the eggs from the ovaries, and fertilized them in
vitro (in the laboratory) with sperm to create embryos.26 Some of the
embryos were implanted into the womb, while the excess embryos were
cryogenically frozen. 27 The creation of embryos in the lab and the ability
to store them indefinitely was revolutionary because it allowed
researchers to study human embryological development from
fertilization. However, because scientists theoretically could create as
many embryos as they needed for clinical and research purposes,
bioethicists29 and religious leaders questioned the morality of such
technology.'
The ensuing controversy over IVF prompted Congress to establish the
Ethical Advisory Board (EAB), a special committee assigned to
investigate whether federal funding for embryo research should be
allocated.3 The EAB issued a report in 1979 that permitted federally
funded embryo research according to the guidelines and limitations
specified in the report, including the requirement that the EAB approve
25. June Coleman, Comment, Playing God or Playing Scientist: A Constitutional
Analysis of State Laws Banning Embryological Procedures, 27 PAC. L.J. 1331, 1336-38
(1996) (explaining in detail the process of 1VF).
26. Id.
27. Id. For an in-depth look at the legal and ethical issues raised by cryopreservation,
see Maria R. Durant, Note, Cryopreservation of Human Embryos: A Scientific Advance, A
Judicial Dilemma, 24 SUFFOLK. U.L. REV. 707 (1990).
28. Green, supra note 23, at 237. The desire to learn more about embryological
development led to the debate over embryo research. See id.
29. Id. at 237 n.7 (referring to Paul Ramsey, Shall We Reproduce?, 220 JAMA 1346
(1972), for an objection to IVF as "unethical medical experimentation").
30. See CATECHISM, supra note 2, T 2377 (articulating the Church's position on
"homologous artificial insemination and fertilization" as "morally unacceptable"
because it separates the sexual act from the procreative act). Therefore, "[tjhe act
which brings the child into existence is no longer an act by which two persons give
themselves to one another." Id.; see also Sacred Congregation for the Doctrine of the
Faith, Donum Vitae ("The Gift of Life"), at pt. 1I, T 5, available at http://www.
nccbuscc.org/prolife/tdocs/donumvitae. htm (last visited September 25, 2001)
[hereinafter Donum Vitae] (clarifying that the good intention of creating a child "is not
sufficient for making a positive moral evaluation of in vitro fertilization," especially
because the standard by "which it is regularly practiced ... involves the destruction of
human beings").
31. See Green, supra note 23, at 238. For purposes of clarification, it is essential to
note that the term "embryo research" entails all research conducted with human embryos,
including ESC research. See generally THE NAT'L BIOETHICS ADVISORY COMM'N,
ETHICAL ISSUES IN HUMAN STEM CELL RESEARCH: EXECUTIVE SUMMARY 1 (1999)
[hereinafter EXECUTIVE SUMMARY].
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research prior to the allocation of funds."a Before the regulations could
be implemented, however, political intervention stalled the EAB's
action.3 3 The Republican administrations of the 1980s achieved a de
facto moratorium on embryo research by diverting funds away from the
EAB and by refusing to nominate EAB members. Therefore, without
any money or members, the EAB could not approve any embryo
research.35  The issue of embryo research resurfaced with the
commencement of the Clinton administration.3
In June 1993, Congress passed the National Institutes of Health
Revitalization Act,37 which eliminated the requirement of EAB approval
for embryonic research.8 The National Institutes of Health (NIH)
formed the Human Embryo Research Panel (Panel) to provide ethical
guidance in the area of embryo research.39 Because of the likelihood that
such research would benefit areas of fertility, genetic defects, and disease
therapy, in September 1994 the Panel recommended that human embryo
research proceed with federal financial backing.i' The NIH accepted the
Panel's recommendations on December 2, 1994 and agreed that federal
funds were necessary to advance human embryo research . On the same
day that the NIH adopted the Panel's guidelines, President Clinton
issued a directive rejecting the portion of the guidelines that allowed
32 See Green, supra note 23, at 238 (referring to Protection of Human Subjects, 44
Fed. Reg. 35,033, 35,057 (1979)).
33. See id. (mentioning, specifically, the Reagan and Bush administrations).
34. See id.
35. Id.
36. See id. (noting that under the Democratic administration of President Clinton,
Congress nullified the requirement that the EAB approve any embryo research, thus
resurrecting the issue by destroying the moratorium); see also Gabriel S. Gross, Comment,
Federally Funding Human Embryonic Stem Cell Research: An Administrative Analysis,
2000 Wis. L. REv. 855, 863 (stating that President Clinton repealed the moratorium
during his second day in office).
37. National Institutes of Health Revitalization Act of 1993, Pub. L. No. 103-43, §
121, 107 Stat. 122, 133 (codified as amended in scattered sections of 42 U.S.C. (1993)).
3& See id.
39. Green, supra note 23, at 238 (revealing that Green was selected for service on the
Human Embryo Research Panel, which met for the first time in January 1994, to provide
ethical guidance in the area of embryo research).
40. Coleman, supra note 25, at 1340 (describing the Panel's attempt to determine
proper guidelines for embryo research in light of the public's views on pertinent issues,
such as when life begins). Genetic defects and disease therapy are two factors driving
scientists' desire to conduct research on ESCs. See NBAC REPORT AND
RECOMMENDATIONS, supra note 12, at 20.
41. Green, supra note 23, at 238 (reporting that the decision to adopt the
recommendations was unanimous).
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embryos to be created for research purposes.42 Essentially, therefore,
only "leftover embryos, 43 from IVF clinics qualified as subjects for
federally funded embryonic research.4 In 1994, nearly twenty years after
the announcment of IVF technology, scientists were on the verge of
obtaining federal funds for embryo research.45
Public outcry over the NIH's decision to allow funding of human
embryo research caused the Republican-controlled Congress, beginning
in 1995, to block research on human embryos through the use of
42. Id. President Clinton's decision posed an interesting ethical dilemma as to why
one would allow research on embryos that have already been created, i.e., IVF embryos,
but not allow embryos to be created for research purposes, i.e., research embryos. By
prohibiting the creation of embryos solely for research purposes, President Clinton's
decision evidences that there is a point at which embryos should be respected as having
the "potential" for life. There seems, however, to be no difference in the end result for the
embryo, for it is destroyed in either process. Therefore, the ethical dilemma for President
Clinton arose not because he opposed the destruction of embryos, but because he did not
want to make human embryos a disposable commodity by funding their creation solely for
research purposes. The author of this Comment questions this logic becasuse the only
difference between IVF embryos and research embryos is the reason for the embryos'
creation. Focusing on this characteristic reshapes the moral question into one of the
researcher's intent and purpose, rather than one of life and death. See EXECUTIVE
SUMMARY, supra note 31, at 2-3 (discussing this ethical consideration further); see also
Rick Weiss, For Senate, 'Stem Cell' Advances Revive Embryonic Controversy, WASH.
POST, Dec. 2, 1998, at A2.
43. See Green, supra note 23, at 239 (defining "leftover embryos" as those that are
usually "destined to be discarded"). Similarly, supporters of ESC research define
"leftover embryos" as those frozen IVF embryos that are "extra" or "slated for
destruction." See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Senator
Orrin Hatch (R-Utah)). However, justifying the destruction of human embryos for
research purposes by claiming they are extra is misleading and founded upon a false
premise. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities). The
embryos "in excess of clinical need" are those embryos presently not needed or wanted by
the parents. However, these parents are given the option of saving the embryos,
discarding them, or donating them to another couple. Id. Even if they are discarded, if we
allow "people's value [to] depend entirely on the extent to which other people 'want'
them, they have no inherent value at all." Id. If one were to value life in such a manner,
then following that logic, it would be morally permissible to use death row inmates and
terminally ill patients for research purposes or kill them to harvest their organs. Id. Note
that the term "leftover embryo" has the same meaning when discussing embryo research
or ESC research.
44. See Green, supra note 23, at 238. Similar arguments are made by proponents of
stem cell research that researchers would limit their stem cell lines to those obtained from
leftover IVF embryos. See, e.g., July 2001 Criminal Justice Hearings, supra note 9
(testimony of Senator Orrin Hatch (R-Utah)); July 2001 Hearings, supra note 5 (statement
of Senator Tom Harkin (D-IA)).
45. See Green, supra note 23, at 238 (noting that the report strongly favored federal
funding of embryo research and, aside from President Clinton's one objection, the Panel's
recommendation had administrative support).
[Vol. 52:437
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appropriations riders to the Department of Health and Human Services
(HHS) budget.46 The appropriations ban, referred to as the "Dickey
Amendment," included any research that threatened the survival of the
embryo - including leftover IVF embryos.47 Beginning in 1995, Congress
continued to renew the congressional ban on federal funding for embryo
research.4 This congressional disapproval forced scientists to hunt down
private financiers or find a new platform upon which they could find a
more favorable ear in Congress.49  Their wishes were satisfied in
November 1998 with the isolation of human ESCsY0
B. The Discovery of Stem Cells: The Proverbial Pandora's Box
On November 6, 1998, the scientific world was astounded by the
announcement of the first successful isolation of human embryonic stem
cells. 51 Two researchers acting independently, James Thomson of the
University of Wisconsin and John Gearhart of Johns Hopkins University,
were the first to cultivate ESCs outside of the human body.52 Each of
these scientists used different means to achieve the same end.53 James
Thomson extracted ESCs from leftover or "surplus" human embryos
from IVF clinics and halted them from developing into various human
tissue. 4 John Gearhart obtained his line of stem cells from the germ cells
46. See Gross, supra note 36, at 865-66 & nn.66-69.
47. See id.; see also Hearing on Embryonic Stem Cell Research Before the Senate
Appropriations Subcomm on Labor, Health and Educ., 106th Cong. (1999) [hereinafter
Nov. 1999 Hearings] (testimony of Congressman Jay Dickey (R-AR)) (explaining his
amendment, which since 1995 has prohibited funding of research on embryos where they
would be discarded or destroyed).
48. See Nov. 1999 Hearings, supra note 47 (testimony of Congressman Jay Dickey (R-
AR), co-author of the riders, which banned federal funding for research that destroys
human embryos); see also Robert L. Bartley, Stem Cells: A Wedge Issue?, WALL ST. J.,
June 11, 2001, at A23.
49. See Green, supra note 23, at 239 (emphasizing that although no federal legislation
prohibits private research on embryos, some state statutes forbid embryo research
whether funded privately or federally).
50. See Langreth, supra note 22 (reporting on the impact of ESC isolation on the
world of science).
51. Id. According to Dr. David Gottlieb of Washington University in St. Louis,
"[t]his is a great big advance that will really open up a large number of applications. The
implications for basic science and biotechnology are huge." Id.
52 Id.
53. See Frederic Golden, Stem Winder, TIME, Aug. 20, 2001, at 27 (reporting on Dr.
James Thomson's ESC research).
54. Id. (announcing that Dr. Thomson was able to stop "their biological clocks by
preventing the cells from morphing into different tissues, as they would in undisturbed
embryos").
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of aborted fetuses.5 Although the announcement excited most of the
scientific community,56 numerous ethical issues needed to be addressed.
Many of these issues reflected the same concerns that opponents of
embryo research expressed throughout the seventies and eighties: 7
While stem cells offered huge potential in numerous realms of medicine,
there were also serious questions about the morality of conducting such
research!"
Possibly even more disturbing than the isolation of human ESCs was
the November 1998 announcement by Advanced Cell Technology
(ACT), a Massachusetts biotechnology company.59 ACT fused a human
cell nucleus with an enucleated cow ovum to create a hybrid line of ESCs
through a process called somatic cell nuclear transfer, or cloning.
60
Although the research went no further,61 the shock created by a research
process that mixed human and animal cells to isolate ESCs, coupled with
the recent announcements of Drs. Thomson and Gearhart, forced
55. Id. (claiming that Dr. Gearhart admitted that Dr. Thomson "was ahead in the
overall race" because Thomson had isolated cells from embryos and not a fetus); For Dr.
Gearhart's explanation of his research, see Hearing on Stem Cell Research Before the
Senate Appropriations Subcomm. on Labor, Health and Human Servs., Educ., and Related
Agencies, 105th Cong. (1998) [hereinafter Dec. 1998 Hearings] (testimony of Dr. John D.
Gearhart, Professor of Gynecology and Obstetrics, Physiology, Biochemistry and
Comparative Medicine, The Johns Hopkins Medical Institutions).
56. See Langreth, supra note 22 (quoting Lana Skirboll, a director of science policy at
NIH, who said it was "tremendously exciting research" because "[o]ne of the great
questions remaining in science is what are the essential events that turn unspecialized cells
... into liver cells or heart cells or brain cells"); see also Dec. 1998 Hearings, supra note 55
(statement of Tom Harkin (D-IA)) (exclaiming his excitement over the discoveries).
57. Weiss, supra note 42; see also Editorial, Magic Cells, WASH. POST, Nov. 9, 1998,
at A22 (stating that pro-life groups and others have opposed research on human embryos,
regardless of their source, as well as research on aborted fetal tissue); Michael Fielding,
Letter to the Editor, Life Itself Becomes Another Commodity, WASH. POST, Nov. 30, 1998,
at A23 (expressing concern over the moral and ethical issues raised by private ownership
and Geron Corp. patents of the recently isolated stem cell lines).
5& See Weiss, supra note 42 (explaining the concerns of ethicists, theologians,
scientists, and Congress about the announcement of stem cell isolation).
59. Miranda Biven, Administrative Developments: NIH Backs Federal Funding for
Stem Cell Research, 27 J.L. MED. & ETHICS 95, 96 (1999).
60. See Dec. 1998 Hearings, supra note 55 (testimony of Michael D. West, Ph.D.,
President and CEO of Advanced Cell Technology, Inc.) (detailing the work performed by
ACT to isolate ESCs from a hybrid embryo).
61. Biven, supra note 59, at 96. An article written on December 14, 1.998 announced
ACT's intent to "create purposefully disabled embryo-like entities... to get around the
emotional debate over the ethics of conducting research on human embryos." Rick Weiss,
Can Scientists Bypass Stem Cells' Moral Minefield?, WASH. POST, Dec. 14, 1998, at A3.
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Congress and the President to reevaluate the changing landscape of
biotechnology.62
President Clinton acted first by asking the National Bioethics Advisory
Commission (NBAC)63 to review all ethical and medical issues involved
in stem cell research.64 The NBAC issued its report in September 1999.6
The Senate Labor, Health and Human Services, Education, and Related
Agencies Subcommittee held its first hearing on the use of embryonic
cells for biomedical research on December 2, 1998.6 The purpose of the
hearing, like the President's commission, was to investigate the issues
surrounding federal funding of embryonic research, especially in light of
the recent medical developments and the previous years' limitation of
federal funding for embryonic research.6 The findings of the NBAC and
the Senate Appropriations Subcommittee eventually played a key role in
the current debate over federal funding of ESC researchi8
C. Avoiding a Research Road Block: The NIH's Interpretation of Federal
Law
While the NBAC conducted its ethical and medical investigation into
ESC research and the Senate Subcommittee reviewed the same, the NIH
attempted to find loopholes in the Omnibus Consolidated and
Emergency Supplemental Appropriations Act, which effectively banned
federal funding of research that would destroy human embryos. 69 Dr.
62. See Weiss, supra note 42.
63. Nat'l Bioethics Advisory Comm'n Charter (1999), available at
http://bioethics.gov/about/nbaccharter.pdf (last visited Sept. 3, 2001) (stating that the
NBAC "will provide advice and make recommendations to the National Science and
Technology Council... on bioethical issues arising from research on human biology and
behavior and the applications.., of that research").
64. Sharon M. Parker, Comment, Bringing the "Gospel of Life" to American
Jurisprudence: A Religious, Ethical, and Philosophical Critique of Federal Funding for
Embryonic Stem Cell Research, 17 J. CONTEMP. HEALTH L. & POL'Y 771, 780 (2001).
65. Id.
66. See generally Dec. 1998 Hearings, supra note 55 (including a variety of medical
testimony from Dr. Harold Varmus, Dr. John Gearhart, Dr. James Thomson, Dr. Michael
West, Dr. Author Caplan, and Dr. Thomas Okarma concerning the successful isolation of
ESCs).
67. Id. (statement of Tom Harkin (D-IA)) (stating, as the Ranking Member of the
Appropriations Subcomm., that the purpose of the hearing was to investigate the scientific
and ethical issues involved in stem cell research).
68. See July 2001 Hearings, supra note 5 (statement of Tom Harkin (D-IA))
(implying that he and Senator Specter (R-PA) introduced S. 723 because of the seven
hearings of the Appropriations Subcomm. on the issue of ESC research); see also Biven,
supra note 59, at 97 (describing NIH's reliance on the NBAC report to formulate
guidelines for ESC research).
69. See Biven, supra note 59, at 96.
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Harold Varmus, then Director of NIH, decided not to ask Congress to
rescind its ban on federal funding for embryonic research and instead
requested the legal opinion of HHS's General Counsel Harriet Rabb
regarding whether the NIH could fund ESC research.70  In a
memorandum to Dr. Varmus in January 1999, Ms. Rabb expressed her
opinion that the ban did not necessarily include human pluripotent stem
cells. 7' Ms. Rabb based her legal opinion upon the scientific fact that
ESCs are not embryos; if implanted in a woman's womb, they would not
develop into human beings.n According to the Omnibus Consolidated
and Emergency Supplemental Appropriations Act for fiscal year 1999,
the term "human embryo" included "any organism... that is derived by
fertilization, parthenogenesis, cloning, or any other means from one or
more human gametes or human diploid cells., 73  From Rabb's legal
standpoint, a stem cell was not an organism, as defined in the scientific
community74 because a stem cell could not carry out all life functions.75
Armed with Rabb's favorable legal interpretation of the congressional
ban, Dr. Varmus convened a subcommittee to draft guidelines by which
ESC research could proceed. However, the subcommittee guidelines
would have to comply with the NBAC's considerations of the legal,
ethical, and medical issues surrounding the research.76
Although many scientists and patient rights advocates encouraged
Congress to support the NIH's decision, its interpretation of the law was
70. George J. Annas, Ulysses and the Fate of Frozen Embryos - Reproduction
Research or Destruction?, 343 NEw ENG. J. MED. 373 (2001) (claiming that the NIH
"decided not to ask Congress to rescind its ban on embryo research but, instead, to
operate within the current rules").
71. Parker, supra note 64, at 777-78 (citing the actual memo from Rabb to Varmus
dated Jan. 15, 1999).
72. Id. (quoting Rabb, who said that stem cells "are not a human embryo within the
statutory definition"). Cf. Jan. 1999 Hearings, supra note 13 (testimony of Richard M.
Doerflinger, Associate Director for Policy Development at the Secretariat for Pro-Life
Activities) (attacking Rabb and Varmus' legal construction as a distortion of the
definitions of embryo and human being because no other legal or scientific source defined
the terms to match those given by Rabb and Varmus in the context of ESC research).
73. Omnibus Consolidated and Emergency Supplemental Appropriations Act, 1999,
Pub. L. No. 105-277, § 511(b), 112 Stat. 2681, 2681-386 (1998).
74. Biven, supra note 59, at 96 (defining "organism" as "an individual constituted to
carry out all life functions").
75. Id. (explaining Rabb's logic in arguing for stem cell exclusion from the federal
funding ban on human embryo research). Cf. Laurie McGinley and Antonio Regalado,
New Theory Could Roil Stem-Cell Debate, WALL ST. J., Aug. 3, 2001, at B4 (claiming that
ESCs, when separated from embryos, naturally tend to heal themselves and revert to
living embryos and therefore the government should not be allowed to fund such
research).
76. See Biven, supra note 59, at 97.
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not without opposition. 77  At the forefront of this debate was
Congressman Christopher Smith (R-NJ), who strongly objected to the
Rabb and Varmus decision.78 Representative Smith argued that Rabb's
interpretation narrowed the meaning of the bill, which deliberately used
broad language, and pointed out that Rabb's definition of a human
embryo evaded the legislative intent of the bill.79 Representative Smith
was not alone." In fact, seventy members of Congress signed a letter to
HHS Secretary Donna Shalala describing the legal opinion of Rabb as a
"carefully worded effort to justify transgressing [the] law."81 Secretary
Shalala responded by reemphasizing the ban's loophole, which allowed
the federal government to fund ESC research as long as no federal
money was used for the actual destruction of the embryo. 82 In addition,
Varmus believed that any moral and legal concerns were outweighed by
the large public constituency that favored the research because of its
possible medical promise."'
In September 1999, the NBAC fulfilled President Clinton's request for
a report outlining the ethical and medical issues involved in embryonic
research, specifically that of human stem cells.8" The report, which later
formed the basis for NIH's guidelines concerning stem cell research,
recommended that funding be extended to those cells derived from
leftover IVF embryos that would otherwise be discarded.8 The NBAC
justified its position in favor of federal funding for ESC research by
emphasizing the substantial potential of the ESCs to benefit those
suffering from serious diseases.86
77. See Rick Weiss, NIH To Fund Controversial Research on Human Stem Cells,
WASH. POST, Jan. 20, 1999, at A2.
78. Parker, supra note 64, at 778-80 (noting that Smith objected "in the strongest
possible terms" to the Varmus decision).
79. Id. (explaining in greater detail Smith's critiques of Rabb's memo).
80. Biven, supra note 59, at 97.
81. Id. (quoting P. Recer, Working Using Fetal Cells Draws Fire, BOSTON GLOBE,
Feb. 18, 1999, at A10); see also Weiss, supra note 20 (quoting Maggie Wynne of the House
of Representatives' Pro-Life Caucus as saying that any research on human embryos would
"violate the letter and spirit" of the ban).
82. Biven, supra note 59, at 97.
83. See Annas, supra note 70, at 297. For Dr. Varmus' statement to the
Appropriations Subcommittee, see Jan. 1999 Hearings, supra, note 13 (testimony of Dr.
Harold Varmus, Director, National Institutes of Health).
84. Press Release, The White House, Statement by the President (Sept. 13, 1999),
available at http://bioethics.gov/ stemcell-pres__statement.htm (last visited Sept. 3, 2001).
85. See EXECUTIVE SUMMARY, supra note 31, at 2-3.
86. See id. at 3 (finding that ESCs "could be important to research and clinical
application because of ... their differing proliferation potential, differing availability and
accessibility, and differing ability to be manipulated").
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The NIH adopted this position and used it to draft its guidelines for
human stem cell research, which it released in December 1999. 8' The
NIH released the draft guidelines to ensure that any research conducted
with federal funds would be carried out in a legal and ethical manner."'
The guidelines contained strict rules for obtaining consent of embryo
donors and required the NIH to establish and maintain a Human
Pluripotent Stem Cell Review Group.89 Regardless of the restrictions
and oversight by the board of review, however, a proper reading of the
appropriations ban and its legislative intent disallows the funding of ESC
research by the government.9
I1. UNDERSTANDING THE POLITICAL, MORAL, AND MEDICAL
SIGNIFICANCE OF THE STEM CELL
A. Defining the Stem Cell
The term "stem cell" has broad application in the scientific world
because it includes cells that originate from an adult, an embryo, a fetus,
or a placenta.9' Yet, too often, the general public has been led to believe
that "stem cells" are what scientists refer to as "human pluripotent stem
cells" or "embryonic stem cells."" The term "stem cell" actually applies
to a number of cells that can divide indefinitely in a culture, giving rise to
more specialized cells.93 The most effective means of understanding the
87. See Biven, supra note 59, at 97; Susan Lee, Human Stem Cell Research: NIH
Releases Draft Guidelines for Comment, 28 J.L. MED. & ETHICS 81, 82 (2000) (stating that
the guidelines were open for public comment from December 2, 1999 through February
22,2000).
88. Parker, supra note 64, at 783 (stating that the guidelines applied to research using
ESCs derived from excess IVF embryos so long as they had not formed a mesoderm).
89. Draft National Institutes of Health Guidelines for Research Involving Human
Pluripotent Stem Cells, 64 Fed. Reg. 67,576-01 (Dec. 2, 1999).
90. See Jan. 1999 Hearings, supra note 13 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(concluding that there is "no clear support in any relevant provision of federal law and
regulations" for the opinion of HHS that produced the guidelines).
91. See Reality Check #2, supra note 12 (defining "stem cells" as those cells that
originate in adult tissue, placentas, umbilical cord blood, or embryos).
92. See id. Cf. EXECUTIVE SUMMARY, supra note 31, at 1 (describing the common
use of "stem cell" in the scientific community as referring to specific cells within the adult
organism, yet claiming the most fundamental stem cells are found in the embryo).
93. Nat'l Institutes of Health, Stem Cells: A Primer, at http://www.nih.gov/
news/stemcell/primer.htm (last visited Sept. 9, 2001) [hereinafter Primer] (presenting
background information and definitions of the various types of stem cells).
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difference between these types of stem cells is to look at the extent to
which they are committed or differentiated for certain roles.94
From a developmental point of view, the fertilized egg has the most
differential potential of all cells because it eventually becomes an entire
organism, including the placenta and umbilical cord.95 The fertilized egg
divides into identical cells within the first few hours of development,
either of which can create an entire organism.6 These cells - the
fertilized egg and the cells into which it divides within the first few hours
- are referred to as totipotent stem cells because of their individual
ability to become entire organisms.97 In other words, if an individual
implanted a totipotent stem cell into a woman's womb, it "has the
potential to develop into a fetus." 98 Once the totipotent stem cells begin
to specialize, usually within four days of fertilization, they form a hollow
sphere of cells with an inner cell mass.99 The inner cell mass consists of
94. See EXECUTIVE SUMMARY, supra note 31, at 1; see also Primer, supra note 93
(explaining that stem cells are "best described in the context of normal human
development").
95. Primer, supra note 93 (stating that a "fertilized egg is totipotent, meaning that its
potential [to form an entire organism] is total").
96. Id. (noting that when the fertilized egg divides into identical cells, if those cells
separate, they become identical twins).
97. Id. (defining totipotent stem cells as those that have unlimited capability and
therefore can give rise to "extraembryonic membranes and tissues [namely the placenta
and umbilical cord], the embryo, and all postembryonic tissues and organs"). Totipotent
stem cells are the precursors to every cell in the body. Id.
98. Id. Interestingly, the NIH specifies that totipotent stem cells can become a fetus
if implanted into the womb, distinguishing them from pluripotent stem cells which cannot.
Id. Such a distinction allows for the argument that a pluripotent stem cell is not an
organism because it cannot grow into a fetus if implanted in the womb. Although this
argument is factually correct, the logic is false because it does not recognize the fact that
the pluripotent stem cells are derived from embryos, which do develop into a fetus if
implanted in the womb. See id. (describing the distinct nature of a pluripotent stem cell
not being able to develop in the womb, but disregarding the nexus between destroying an
embryo to obtain the stem cells and that embryo's developmental capabilities); see also
Rick Weiss, Ban on "Stem Cell" Testing Reviewed; At Senate Hearing, Advocates Offer
Evidence of Research's Medical Promise, WASH. POST, Dec. 3, 1998, at A2 (quoting Dr.
Harold Varmus, Director of the NIH, as saying that the ESCs deserve "special ethical
consideration," but tempering the statement by announcing that ESCs "cannot be
considered organisms and cannot be considered embryos").
99. Compare Primer, supra note 93 (defining the hollow sphere of cells as a
blastocyst, which consists of an outer layer of cells - the hollow sphere - and the inner cell
mass), with STEDMAN'S MEDICAL DICTIONARY 581 (2000) (defining a human embryo as
"an organism in the early stages of development" and "a developing organism from time
[of] conception to approximately the end of the second month"), and VAN NOSTRAND'S
SCIENTIFIC ENCYCLOPEDIA 943 (5th ed. 1976) (defining the embryo as the individual
created "[a]t the moment the sperm cell of the human male meets the ovum of the female
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pluripotent stem cells, which eventually develop into all of the body's
different tissues.'0° It is these cells over which the ethical, political, and
social debate has arisen.' °1
Pluripotent stem cells undergo further differentiation to create
multipotent stem cellsj02 which have a more specialized function. 3
Multipotent stem cells, unlike pluripotent stem cells, do not individually
give rise to all tissue cells.IIA This difference does not mean that
and the union results in a fertilized ovum" and stating that "[t]he term embryo covers the
several stages of early development from conception to ninth or tenth week of life").
1.00. NBAC REPORT AND RECOMMENDATIONS, supra note 12, at 9 (supplying a
visual aid that illustrates the primary stages of embryological development, including an
explanation in the text).
101. Compare id. (assuming that if stem cells were to be used for the treatment of
disease, pluripotent stem cells would be the most advantageous), with United States
Conference of Catholic Bishops, Stem Cell Reality Check #1, at http://www.nccbuscc.
org/prolife/issues/bioethic/stemfaxl.htm (last visited Sept. 2, 2001) [hereinafter Reality
Check #1] (debunking the myth that "embryonic stem cells are the most effective for
treating disease" because "[e]mbryonic stem cells have not helped a single human patient
or demonstrated any therapeutic benefit," while noting that adult stem cells and other
ethical alternatives have helped hundreds of thousands of patients with juvenile diabetes,
spinal cord injury, immune deficiency, and corneal problems).
102. These cells are popularly known as adult stem cells due to their existence in the
tissues and bodies of grown adults. See NBAC REPORT AND RECOMMENDATIONS, supra
note 12, at 8. The cells of the body have a limited lifespan and upon the cells' death are
replaced by the stem cells from that tissue's reserves. Id.
103. See Primer, supra note 93. Interestingly, the NIH implies that multipotent stem
cells are predestined to develop into only those cells for which they are specialized (e.g.,
blood stem cells only having the ability to develop into different blood cells). See id.
However, numerous private and publicly conducted studies show that adult stem cells of
one tissue type show promise of converting to other tissue types (e.g., blood stem cells
being used to replenish nerve cells). See Rick Weiss, Researchers Transform Bone
Marrow From Adults, WASH. POST, Aug. 15, 2000, at A6 (reporting that "[a]dult bone
marrow cells can be coaxed into becoming what appear to be nerve cells"); see also United
States Conference of Catholic Bishops, Current Clinical Use of Adult Stem Cells To Help
Human Patients, at http://www.nccbuscc.org/prolife/issues/bioethic/.adult70l.htm (last
visited Sept. 2, 2001); Laurie Johannes, Adult Stem Cells Have Advantage Battling
Diseases, WALL ST. J., Apr. 13, 1999, at B1; Rick Weiss, Human Fat May Provide Useful
Cells, WASH. POST, Apr. 10, 2001, at Al (reporting that scientists transformed fat cells
into different tissue types).
104. For example, the body's hematopoietic stem cells are found in the bone marrow
and give rise to platelets, white blood cells, and red bloods cells, replenishing the cells the
body loses or uses everyday. See NBAC REPORT AND RECOMMENDATIONS, supra note
12, at 12 (explaining that skin epithelium stem cells and small intestine epithelium stem
cells generate the replacement cells for the short-lived cells of those tissue types); see also
Primer, supra note 93 (describing multipotent stem cells as more specialized than
pluripotent stem cells). Cf. Hearing on Stem Cell Research Guidelines Before Senate
Appropriations Subcomm. on Labor, Health and Human Servs., and Educ., 106th Cong.
(2000) [hereinafter Sept. 2000 Hearings] (testimony of Dr. David A. Prentice, Ph.D.,
Professor of Life Sciences, Indiana State University; Adjunct Professor of Medical and
Molecular Genetics, Indiana University School of Medicine; Founding Member, Do No
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multipotent stem cells lack the medical potential that pluripotent stem
cells are professed to retain.105 In fact, multipotent stem cells are the only
form of stem cells clinically used to treat human patients,'O6 and they are
a viable and proven alternative to the use of controversial ESCs.u°n Yet,
scientists still push for permission to conduct research on pluripotent or
embryonic stem cells, whose success is speculative at best.1°8
Harm: The Coalition of Americans for Research Ethics) (debunking the myth that adult
stem cells can only develop into cells of their own tissue type by reporting that bone
marrow stem cells can "take up a 'new job description' and be changed into neurons" as
well as "form bone, cartilage, muscle, and fat cells").
105. See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (indicating that
reports about the ineffectiveness of adult stem cells "are not relevant to their therapeutic
potential and/or overstate the differences between adult stem cells and embryonic stem
cells" and claiming that "adult stem cells can be pluripotent and have the ability to
transform from one cell type into another"); see also Sept. 2000 Hearings, supra note 104
(testimony of Dr. David A. Prentice, Ph.D., Professor of Life Sciences, Indiana State
University; Adjunct Professor of Medical and Molecular Genetics, Indiana University
School of Medicine; Founding Member, Do No Harm: The Coalition of Americans for
Research Ethics) (claiming that human ESCs have not proved themselves able to generate
all tissues in the body yet are assumed by proponents of ESC research to have the ability
to do so).
106. Current Clinical Use, supra note 103 (stating that embryonic (pluripotent) stem
cells have never helped a human patient, yet multipotent (adult or mature) stem cells are
used clinically to treat approximately twenty-five diseases, including autoimmune diseases,
stroke, immunodeficiencies, anemia, Epstein-Barr, corneal damage, liver and blood
diseases, and cancer); see also July 2001 Criminal Justice Hearings, supra note 9 (testimony
of Dr. David A. Prentice, Ph.D., Professor of Life Sciences, Indiana State University;
Adjunct Professor of Medical and Molecular Genetics, Indiana University School of
Medicine; Founding Member, Do No Harm: The Coalition of Americans for Research
Ethics) (reporting that "an impressive volume of scientific literature attests to the fact that
human adult stem cells - unlike human embryonic stem cells - are currently being used
successfully in clinical trials to combat many of the very diseases that embryonic stem cells
only prospectively promise to treat"). Indeed, the ESCs that are touted as having such
potential "have not even shown their efficacy in animal models." Id.
107. See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (noting that
"adult stem cell research is a preferable alternative" because of its progress in
regenerative medicine and cell-based therapies and its lack of medical, legal, and ethical
problems); see also Johannes, supra note 103 (reporting that it will be much easier to turn
multipotent stem cells, rather than embryonic stem cells, into treatments because
multipotent stem cells are "further along in their development, . . . [which creates]
potential injectable therapies that would harness the body's capacity to regenerate itself").
108. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(testifying to the loss of enthusiasm over ESC research because, in the lab, ESCs are
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B. What is the Gospel of Life?
Surprisingly, the phrase "Gospel of Life" is not found in the Bible but
is understood through Sacred Tradition °9 as an essential aspect of
Christ's message. ° The idea of the Gospel of Life is based on Christ's
explanation of his redemptive mission in the Gospel of John: "I came
that they may have life, and have it abundantly. ' .. Offering life eternal
was at the heart of Jesus' message and the very reason for his becoming
man. The Second Vatican Council determined that "[b]y his
Incarnation the Son of God has united himself in some fashion with
every human being.'1 3
According to the Catholic faith, through Christ people are called to
communion with the Father and share in the very life of God."4
Therefore, each person's life is a divine gift from God, as the Creator,
which must be respected, protected, and preserved."' This basic tenet of
Catholic belief - that all stages of life are significant - forms the
foundation upon which the Gospel of Life is understood. 6 Essentially,
the Catholic belief is that "[e]very human life, from the moment of
harder to maintain than once thought and are more difficult to coax into tissue cells than
their mouse counterparts).
109. Sacred Tradition, coupled with Sacred Scripture, makes up the Church's
understanding of the Word of God. CATECHISM, supra note 2, 1 97. Sacred Tradition is
the apostles' understanding of the Word of God passed through their successors to the
Magisterium of the Church. Id. 83, 96.
110. See Evangelium Vitae, supra note 17, 1.1 n.1.
111. Id. 91 1.3 (quoting John 10:10 and clarifying that the "life" to which Jesus referred
is the "'new' and 'eternal' life to which everyone is called).
112. See John 3:1.4-16 ("[T]he Son of Man [must] be lifted up, so that everyone who
believes in him may have eternal life. For God so loved the world that he gave his only
Son, that everyone who believes in him might not perish but might have eternal life.").
The famous verse of John 3:16 is, essentially, the whole of the Christian faith summarized
into one sentence. Professor Raymond Marcin, Address at the Guild of Catholic Lawyers
Weekly Bible Study (Oct. 26, 2001).
113. Evangelium Vitae, supra note 17, 9 2.3 (quoting Gaudium et Spes T1 22).
114. Evangelium Vitae, supra note 17, 9 1.3. For a prophetic annunciation of this
tenet, see Job 12:10 (recognizing that in God's "hand is the soul of every living thing, and
the life breath of all mankind").
115. Evangelium Vitae, supra note 17, T 2.1 (calling life on earth a "sacred reality
entrusted to us, to be preserved with a sense of responsibility and brought to perfection in
love and in the gift of ourselves to God and to our brothers and sisters"); see also
CATECHISM, supra note 2, $ 2258 (claiming that "[h]uman life is sacred because from its
beginning it involves the creative action of God and it remains for ever in a special
relationship with the Creator, who is its sole end").
116. Evangelium Vitae, supra note 17, 9 1.3. Christ's sacrifice allowed for a new
eternal life to which "every person is freely called in the Son by the power of the
Sanctifying Spirit. It is precisely this 'life' that all the aspects and stages of human life
achieve their full significance." Id.
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conception until death, is sacred because the human person has been
willed for its own sake in the image and likeness of the living and holy
God.""' 7 In Evangelium Vitae, Pope John Paul II expounds upon this
aspect of the Catholic faith so that we may have a full understanding and
respect for human life.
118
Recognizing the growing international threat to life at its weakest
stages, Pope John Paul II conveyed to the world the inviolability of all
human life in his 1995 papal encyclical, Evangelium Vitae."9
Emphasizing the universal importance of the subject matter, John Paul
addressed the encyclical not only to the usual bishops, priests, deacons,
men and women religious, but to "lay faithful and all people of good
will." 20 The encyclical developed the meaning of the Gospel of Life and
its applicability to all human beings, not just Catholics. 2 ' John Paul
considered it applicable to all those of good will because the sanctity of
life is a concern for all; indeed, he claims that "[t]he value at stake is one
which every human being can grasp by the light of reason."2 John Paul
is convinced that the truths of the Gospel of Life are part of the heart
and conscience of everyone, and therefore, anyone open to truth and
goodness will recognize the sanctity of life at all stages and affirm it as a
primary good worthy of our utmost respect. 23 Although John Paul
117. CATECHISM, supra note 2, $ 2319; see WILLIAM E. MAY, CATHOLIC BIOETHICS
AND THE GIFT OF HUMAN LIFE 23-24 (2000) (explaining that "[h]uman life . . . is
precious, in itself and to God, at every moment of its existence... [and] indeed, the whole
of God's law, his wise and loving plan for human existence, fully protects human life").
118. See J. Michael Miller, Editor's Introduction to John Paul II, Evangelium Vitae, in
THE ENCYCLICALS OF JOHN PAUL II 663, 664 (J. Michael Miller ed., 2001) [hereinafter
Editor's Introduction].
119. See id. at 663 (explaining the Pope's defense of human dignity against scientific
threats to human life, which has repercussions for the core of the Church's teaching and
faith).
120. Evangelium Vitae, supra note 17, at Title Page (stating the title of the encyclical,
which includes from whom the document originates and to whom it is directed).
121. Id. $ 5.5-5.6 (revealing that the encyclical was "the fruit of the cooperation of
the Episcopate of every country ... [and is] addressed to each and every person in the
name of God ... [and] all people of good will who are concerned for the good of every
man and woman" such that they "respect, protect, love and serve life, every human life!");
see also id. 101.2 ("The Gospel of life is not for believers alone: it is for everyone. The
issue of life and its defense and promotion is not a concern of Christians alone.").
122. Id. $$ 101.2, 83.1-83.3 ("[W]e have been sent into the world as a 'people for life,"'
who must "foster in ourselves and in others a contemplative outlook" through which we
"rediscover the ability to revere and honor every person," including those in all stages of
life).
123. See Editor's Introduction, supra note 118, at 664 (quoting the encyclical, Miller
states that from creation the Gospel of Life is written on everyone's heart and is echoed in
everyone's conscience); see also CATECHISM, supra note 2, $ 2323 ("Because it should be
Catholic University Law Review
specifically addressed the popular right to life concerns of the 1990s, 24 his
teachings on the Gospel of Life transcend time and apply to any subject
regarding the sanctity of human life.'2
III. LEGISLATING THE STEM CELL: THE THREE PROPOSALS FOR
FEDERAL FUNDING OF STEM CELL RESEARCH
A. Introduction
Since the breakthrough isolation of ESCs, the social, ethical, medical,
and political debate has raged over the law regarding stem cell
research.26 This debate has produced a number of opinions as to what
types of research should be federally funded and reflects the tension
between the scientific desire for knowledge and the moral imperative not
to kill.' 2 From this political debate arose three proposals that span the
federal funding spectrum; on one extreme is Senator Specter's Stem Cell
Research Act of 2001 and on the other is Senator Ensign's Responsible
Stem Cell Research Act of 2001, with President Bush's proposal falling
somewhere in between the two separate proposals.128 Each proposal
identifies the type of research that should be allowed and the type of
stem cells that may be used. 29
treated as a person from conception, the embryo must be defended in its integrity, cared
for, and healed like every other human being.").
124. Editor's Introduction, supra note 118, at 664 (discussing three doctrinal
pronouncements from the encyclical: the "direct and voluntary killing of innocent human
life," abortion, and euthanasia).
125. See Evangelium Vitae, supra note 17, 95.2. The encyclical calls for a "general
mobilization of consciences and a united ethical effort to activate a great campaign in
support of life. All together, we must build a new culture of life.- new, because it will be able
to confront and solve today's unprecedented problems affecting human life." Id. See
generally WILLIAM N. SEIFERT ET AL., PROCLAIMING THE GOSPEL OF LIFE: A
SUMMARY & COMMENTARY ON THE GOSPEL OF LiFE (1996) (providing a guide for
living the Gospel of Life in one's daily life and offering a deeper understanding of the
encyclical through its summaries, background information, and commentary).
126. See Bartley, supra note 48 (labeling federal funding for ESC research as the least
understood, yet "most delicate and most interesting social-policy decision facing the young
Bush administration").
127. See id. (pointing out that ESC research causes the "imperative of science - do not
impede knowledge - [to] clash[] with the imperative of morality - do not kill").
128. Compare Stem Cell Research Act of 2001, S. 723, 107th Cong. (2001) (allowing
for leftover IVF embryos to be used as the source of ESCs), and Responsible Stem Cell
Research Act of 2001, S. 1349, 107th Cong. (2001) (promoting the use of those stem cells
deemed by the bill to be responsible as the source for ESCs and therefore obviating the
need for any embryos to be destroyed), with Bush Proposal, supra note 5 (selecting for
research only the sixty ESC lines in existence at the time the proposal was made).
129. Compare Bush Proposal, supra note 5, (using only prexisting isolated ESC lines to
perform a wide variety of research and clinical applications) and Stem Cell Research Act
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B. Broad Usage of Embryonic Stem Cells: The Stem Cell Research Act of
2001
Senator Arlen Specter, current Chairman of the Senate
Appropriations Subcommittee on Labor, Health and Human Services,
Education, and Related Agencies, introduced his stem cell research bill
in the Senate on April 5, 2001."3 The purpose of the Specter Bill is to
explore the potential of ESCs by amending the Public Health Service Act
to allow for the generation of and research on human embryonic stem
cells."' Specifically, the Specter Bill allows the Secretary of HHS to
"conduct, support, or fund research on human embryos for the purpose
of generating embryonic stem cells and utilizing stem cells that have been
derived from embryos."'32  However, the sources of the ESCs are
restricted to embryos donated from IVF clinics, so long as certain
requirements are met.33 The Specter Bill places two requirements on all
donated IVF embryos: (1) that the progenitors'4 be properly consulted
to determine that the embryo[s] would never be implanted in a woman,
and (2) that the progenitors donate the embryo[s] with written informed
of 2001, S. 723, 107th Cong. (2001) (using ESCs derived from leftover 1VF embryos to
conduct research in hopes of helping individuals with debilitating diseases), with
Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. (2001) (preserving the
lives of embryos by disallowing their use for research purposes, while promoting further
research and clinical application of those stem cells that are already treating numerous
diseases as well as establishing a nationwide stem cell donor bank to ensure proper genetic
matches for all patients).
130. Stem Cell Research Act of 2001, S. 723, 107th Cong. (2001) (introducing the bill
on behalf of Mr. Harkin, Mr. Thurmond, Mr. Chafee, Mr. Smith of Oregon, Mr. Hollings,
Mr. Reid, Mrs. Murray, Mrs. Clinton, Mr. Corzine, Mrs. Feinstein, Mr. Kerry, and Mr.
Inouye).
131. See Aug. 2001 Hearings, supra note 5 (statement of Senator Arlen Specter (R-
Pa.)) (stating that he introduced the bill to lift the ban prohibiting federal funding for ESC
research because of the "phenomenal" benefits of ESCs); see also Stem Cell Research Act
of 2001, S. 723, 107th Cong. § 2 (2001).
132. Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001).
133. Id. (outlining the two restrictions placed on embryos donated from IVF clinics).
The donation aspect is important because the Specter Bill does not seek to promote a
market for the sale of human embryos. Id. (making it unlawful to "knowingly acquire,
receive, or otherwise transfer any human embryos for valuable consideration").
134. "Progenitor" is a neutral term that describes the sperm and egg donors to the
embryo. Referring to the sperm and egg donors as "mother" and "father" undermines the
idea that an embryo is not a person, but rather a "form of life" that deserves respect. See
EXECUTIVE SUMMARY, supra note 31, at 2 (claiming that "most would agree that human
embryos deserve respect as a form of human life"). Note that the EXECUTIVE SUMMARY
does not define what a "form of human life" is, nor does it explain how such a designation
affects its findings. See id.
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consent. 135  The Specter Bill also places some restrictions and
prohibitions on the acquisition of and research on the embryos to
prevent scientists from having free reign over the "form of human life"
that is the embryo.' 36
The restrictions placed on federally funded ESC research prohibit
research that would create human embryos or that would result in
reproductive cloning of a human being. 37 These restrictions follow the
NBAC's recommendations, which prohibit federal funding of the
creation of research embryos and somatic cell nuclear transfer (SCNT) 38
The term "research embryo" refers to those embryos created by donor
gametes - an egg and a sperm - with the sole intent of deriving stem
cells.'39 The technical process of SCNT is better known as a form of
cloning because a human or other animal egg is enucleated, and the
nucleus of an adult somatic cell'O is inserted. 4' The Specter Bill places
135. Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001) (describing what
would be §498C(b)(1-2) if the bill were enacted, which details these two restrictions on
donation). Cf. EXECUTIVE SUMMARY, supra note 31, at 4 (advising the President in
Recommendation 2 to allow for the use of ESCs derived from IVF embryos, but also
requiring certain oversight and review measures found in Recommendations 5-9).
136. Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001) (describing what
would be "restrictions" and "prohibitions" on research if the bill were enacted). The
Specter Bill specifically restricts the creation of human embryos for research purposes and
the reproductive cloning of a human being. Id. It also prohibits the sale of human
embryos, so as not to create a market where human embryos would be sold for valuable
consideration. See id.
137. See id.
13& See EXECUTIVE SUMMARY, supra note 31, at 5-6 (recommending that federal
agencies should not fund research that would create embryos simply for research purposes
or use somatic cell nuclear transfer to create embryos for research purposes). The NBAC
explains that "there is no compelling reason at this time to provide federal funds for the
creation of embryos for research" because embryos from IVF clinics presently provide an
.adequate supply. Id. at 5. The NBAC leaves the door open for future use of research
embryos. See id. In fact, the commission implies that the use of research embryos may be
necessary if IVF technologies improve and the supply of IVF embryos diminishes. See id.
Furthermore, the NBAC claims that research embryos may be the only means of studying
the human fertilization process. See id. Similarly, in discussing the funding of SCNT, the
NBAC recognizes that SCNT may have significant therapeutic potential and therefore
recommends monitoring its scientific progress and utility. See id. at 6.
139. EXECUTIVE SUMMARY, supra note 31, at 5 (stating that there is a "morally
relevant difference" between an embryo created for IVF purposes and those created
solely for research grounded upon the "avoid[ance of the] instrumental use of human
embryos").
140. Primer, supra note 93 (defining a somatic cell as any bodily cell other than a
sperm or an egg).
141. Id. (defining somatic cell nuclear transfer as transferring a somatic cell nucleus
into an egg that is without its nucleus); see also NBAC REPORT AND
RECOMMENDATIONS, supra note 12, at 19 (detailing the process of SCNT used by
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these restrictions upon the type of research and embryos from which
ESCs may be extracted presumably because IVF embryos are in
abundance and would otherwise go to waste; use of other embryos is
142
simply unnecessary.
The prohibition annunciated by Senator Specter's Bill targets the
transfer of IVF embryos for valuable consideration. 43 It specifically
states, however, that valuable consideration does not include any costs
incurred by "transportation, transplantation, processing, preservation,
quality control, or storage."144 This prohibition addresses the concern
that a market for embryos would be inadvertently created. 14  The
Specter Bill, therefore, prohibits the exchange of money for embryos,
except for the payment of costs associated with the donation process.46
The Specter Bill amounts to an allowance of enough research so as to
gain a deeper understanding of the potential of embryonic stem cell
research, yet provides a minimal bar for uncertain or unnecessary forms
of research. 47
C. Narrow Stem Cell Research: The Responsible Stem Cell Research Act
of 2001
Shortly after Senator Specter introduced the Stem Cell Research Act
of 2001, Senator Ensign responded with a bill of his own - the
Responsible Stem Cell Research Act of 2001.'" The Ensign Bill, unlike
Advanced Cell Technology, Inc. to create a hybrid embryo and to extract the cells
resembling the human ESCs).
142. See EXECUTIVE SUMMARY, supra note 31, at 5-6.
143. Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001).
144. Id.
145. See Dec. 1998 Hearings, supra note 55 (statement of Senator Tom Harkin (D-
IA)) (acknowledging that the market interest in stem cell research is strong, but that it is
important to allocate federal funds for the research to ensure that researchers meet certain
ethical guidelines). Cf. EXECUTIVE SUMMARY, supra note 31, at 7 (advising that embryos
should not be bought or sold and observing that once society and science agree that
creating embryos for therapeutic purposes is justified, the prohibitions on donations
should be reevaluated).
146. See Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001) (allowing for
the payment of reasonable expenses associated with donating an embryo for research).
147. See July 2001 Hearings, supra note 5 (statement of Senator Tom Harkin (D-IA))
(clarifying that both he and Senator Specter feel ESC research is promising and believe
that the government's financial support is imperative for scientific and ethical purposes);
see also Aug. 2001 Hearings, supra note 5 (statement of Senator Arlen Specter (R-PA))
(expressing his belief that ESC research is the most important issue facing Congress
because it has the potential to cure millions).
148. Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. (2001)
(introducing the bill on August 3, 2001 for himself and Senator Brownback).
Catholic University Law Review
the Specter Bill, recites congressional findings 149 and offers a viable
solution in the form of a National Stem Cell Donor Bank that would act
as a depository for qualifying stem cells that could be used for research
150purposes.
The fundamental difference between the Ensign Bill and the Specter
Bill is the definition of the types of stem cells that qualify for research.1 51
Qualifying stem cells under Ensign's Bill are defined by their origin,
specifically naming those "obtained from human placentas, umbilical
cord blood, organs or tissues of a living or deceased human being who
has been born, or organs or tissues of unborn human offspring who died
of natural causes (such as spontaneous abortion)."'' 2 The Ensign Bill
establishes a National Stem Cell Donor Bank to "seek and preserve
donations of qualifying human stem cells and to make such donated cells
available for biomedical research and for therapeutic purposes.' ' 53 For
ease of operation, the Secretary of HHS would run the donor bank; keep
a patient registry; and establish criteria for quality standards, donor
selection, and transportation and collection for those participating in the
research."'A
Although Senator Ensign enunciated his reasons for proposing this bill
in the section on findings, the actual characterization of the types of
qualifying stem cells clearly demonstrates that Senator Ensign designed
his bill to focus scientific energy and government funding on stem cell
research that has proven to be effective. 55  Unlike the Specter Bill, the
149. Id. § 2 (finding, among other things, that investing in biomedical research has
improved the quality of life, that many Americans still suffer from a number of
debilitating diseases, that recent scientific developments in ethical stem cell research could
help alleviate suffering and possibly cure these diseases, and that federal funding of ethical
stem cell research must be expanded).
150. Id. §§ 2-4 (organizing the bill such that section two includes the findings, section
three defines the donor bank and qualifying cells, and section four explains permissible
usages).
151. Compare Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. §
3(b) (2001) (defining qualifying stem cells as those obtained from placentas, umbilical
cords, organs and tissues of living or deceased human beings, or spontaneously aborted
fetuses), with Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001) (allowing for
research upon stem cells extracted from donated leftover IVF embryos).
152. Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 3(b) (2001).
153. See id. § 3(a).
154. See id. § 3(c)-(e).
155. See id. § 2; see also Karen D. Brown, 'Biological Insurance' for Your Baby;
Experts Debate the Value and Ethics of Banking Umbilical Cord Blood To Collect Stem
Cells, WASH. POST, Sept. 12, 2000, at Z12 (reporting that new research shows that blood
from the placenta and umbilical cord, like bone marrow, contain valuable stem cells that,
upon transplantation, could cure numerous diseases). It is important to note that the
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Ensign Bill completely excludes ESCs from federally funded research
and instead appropriates $275 million to the NIH for research on
qualifying stem cells.156 Therefore, by defining and funding research on
specific types of stem cells, the Ensign Bill attempts to avoid the ethical
dilemmas surrounding the Specter Bill.
D. The Middle Ground: President Bush's Proposal for Stem Cell
Research
On August 9, 2001 President Bush made the most anticipated speech
of his young presidency regarding a hotly debated political topic - his
decision on the fate of federal funding for stem cell research.157 In
deciding to "proceed with great care," the President sought a
compromise between those who seek more funding for research and
those who desire a complete elimination of the research.'58 With much
deliberation, the President decided to allow federal funding to further
research on stem cell lines159 that were already in existence.O This
Ensign Bill did not outlaw the use of ESCs derived from embryos because the
appropriations rider discussed previously, which was still in effect at the time Senator
Ensign introduced his bill, already banned the destruction of embryos in research. See
supra Part I.A. Due to the nature of the stem cells proposed for use by the Ensign Bill,
they were not banned from receiving funding because they did not require the destruction
of human embryos. See Nov. 1999 Hearings, supra note 47 (testimony of Congressman Jay
Dickey (R-AR)) (describing that the purpose of the ban was to hinder funding research
methods that would cause the destruction or discarding of embryos).
156. See Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong., § 4(b)
(increasing significantly the NIH budget as a means of promoting ethically sound stem cell
research).
157. See Amy Goldstein & Mike Allen, Bush Backs Partial Stem Cell Funding, WASH.
POST, Aug. 10, 2001, at Al (describing President Bush's first presidential announcement
as "politically charged"); see also Mike Allen, Bush Suggests an Aug. 21 Decision on Stem
Cell Research, WASH. POST, Aug. 9, 2001, at A5 (announcing that the highly anticipated
Bush decision on federal funding for stem cell research would come before Labor Day);
Chris Adams, Congress Braces for Vigorous Debate on Bush's Stem-Cell Funding, WALL
ST. J., Aug. 31, 2001, at A10 (referring to President Bush's decision to limit ESC research
as a struggle).
158. See Bush Proposal, supra note 5. President Bush described the research as
offering "both great promise and great peril, so [he] decided [to] proceed with great care."
Id.; see also Adams, supra note 157 (labeling President Bush's decision as an attempt to
walk a fine line between the supporters of ESC research and opponents of ESC research);
William J. Livolsi Jr., Editorial, A Sound Stem Cell Decision, WASH. POST, Aug. 12, 2001,
at B6 (praising President Bush for making a sound decision based on a careful weighing of
benefits and ethical concerns).
159. A "stem cell line" is a group of ESCs that have been extracted from the embryo
and, basically, are multiplying indefinitely in laboratories across the world. See Mitch
Frank, The Bush Decision, TIME, Aug. 20, 2001, at 18 (defining an ESC line as the product
of extracting ESCs from an embryo and, under the right conditions, replicating them in a
Petri dish without the ESCs differentiating into specific tissue cells).
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decision essentially eliminated any other ESCs derived from IVF
embryos, no matter what the embryos' fate, from federally funded
research.1 6' The President felt that there was a moral line that he did not
want to cross: destroying human embryos for research purposes.162
Bush's proposal did not eliminate adult, umbilical cord, placenta, or
animal stem cell research from federal funding; rather, he specifically
included them. 63 In addition, to monitor the field of stem cell research,
President Bush formed a President's council to consider the medical and
ethical ramifications of such research and recommend appropriate
research guidelines.6
Although President Bush's proposal was not fully in accord with either
of the Senate bills, it represented an attempt to find a middle ground.
165
President Bush recognized the importance of stem cell research to the
medical and clinical community, yet he also empathized with the moral
concerns of destroying embryos for research.' 66 Essentially, he attempted
160. See Bush Proposal, supra note 5 (claiming that "we should allow federal funds to
be used for research on these existing stem cell lines," meaning those in existence at the
time of the decision).
161. See Amy Goldstein & Mike Allen, Bush Backs Limited Funding for Research on
Stem Cells, WASH. POST, Aug. 12, 2001, at A3 (reporting that President Bush's proposal
allows the use of federal grant money solely for already harvested ESC but prohibits
subsidies for research that would create or destroy additional embryos).
162. See Bush Proposal, supra note 5 (clarifying that research on the sixty or so
existing stem cell lines would allow for exploration of "the promise and potential of stem
cell research without crossing a fundamental moral line, by providing taxpayer funding
that would sanction or encourage further destruction of human embryos").
163. See id. (propounding the belief that "great scientific progress can be made
through aggressive federal funding of research on umbilical cord placenta, adult, and
animal stem cells"); see also Mitch Frank, The Research Effect, TIME, Aug. 20, 2001, at 20
(depicting in a graphic the different forms of stem cells receiving funding under President
Bush's plan).
164. Bush Proposal, supra note 5 (appointing Dr. Leon Kass, a biomedical ethicist at
the University of Chicago, as chairman of the council); see Howard Fineman et al., Stem
Cell Line, NEWSWEEK, Aug. 20, 2001, at 17-18 (characterizing Dr. Leon Kass as a key
figure in advising President Bush on his stem cell research decision).
165. See Laurie McGinley & Jeanne Cummings, Bush To Allow Limited Stem-Cell
Funding, WALL ST. J., Aug. 10, 2001, at A3 (explaining that President Bush's decision
allowed him to give a little to each side of the debate without alienating the other); see also
Nancy Gibbs & Michael Duffy, "We Must Proceed With Great Care," TIME, Aug. 20,2001,
at 15 (recounting President Bush's demeanor as humble because looking like a "national
priest" or "capitalist tool" would enrage one side and cause more division). Cf. Michael E.
Ruane, Stem Cell Decision Only Adds to Debate, WASH. POST, Aug. 11, 2001, at B1 (using
examples of individuals' reactions to the President's decision to show how his decision
fueled the debate rather than quelled it).
166. See Bush Proposal, supra note 5 (stating that he is a "strong supporter of science
and technology ... [as] they have the potential for incredible good" and that he believes
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to appease both sides by allowing some ESC research but limiting it to
those ESCs "where the life and death decision has already been made."'167
Although some find this to be a satisfactory compromise, for others,
President Bush's proposal fuels the political, ethical, and medical
debate.'6
IV. LEGISLATING THE GOSPEL OF LIFE?: DENYING THE DEVALUATION
OF HUMAN LIFE THROUGH LEGISLATION
A. With What Should We Be Concerned?
The legislative and administrative intent behind all three proposals for
stem cell research is expressly or implicitly an attempt to do what is best
for society.' 6 However, the question for Catholics - and those that Pope
John Paul II described as individuals of "good will"'7 - is not whether
the intent behind the proposal is good, but rather each proposal's effect
on the basic tenets of the Catholic tradition; in other words, the real
"human life is a sacred gift from our Creator" and worries "about a culture that devalues
life").
167. Bush Proposal, supra note 5; see McGinley & Cummings, supra note 165 (stating
that President Bush's proposal allowed the President to "argue to his antiabortion
supporters that no additional embryos would be destroyed under his plan" and to "give
something to those.., who want the federal government to take some step to advance
what could be promising research").
168. See Ruane, supra note 165 (quoting one politician as urging President Bush not to
cut off funding for ESC research, while also noting the Archbishop of Washington's
disappointment in the President's decision); see also Rick Weiss, Promising More and
Less; Scientists See Growth in Field, Lament Limits, WASH. POST, Aug. 10, 2001, at Al
(raising the issue that thousands of scientists who rely on federal funding for research see
the Bush decision as a "boon to research" and a restriction on the "ability to generate
certain kinds of knowledge").
169. See Today, WASH. POST, July 6, 2001, at A24 (quoting the NBC television
broadcast, July 5, 2001). Interviewing Senator Specter, Matt Lauer asked, "Why are you
in favor of funding stem-cell research?" Senator Specter responded by claiming that
"these embryonic stem cells hold the potential for being a veritable fountain of youth."
Id.; see also Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 2 (2001)
(outlining congressional findings that investments in biomedical research have improved
the quality of life of many Americans and that "[r]ecent scientific developments show that
[ethically responsible] human stem cell research . . . may lead to exponential
improvements in the treatment of many terminal and debilitating conditions"); Bush
Proposal, supra note 5 (explaining that "research on these 60 lines has great promise that
could lead to breakthrough therapies and cures").
170. See supra notes 119-25 (explaining the significance of the Pope addressing
Evangelium Vitae to more than just Catholics, but all individuals of "good will," and why
the encyclical is applicable to everyone).
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question is whether each proposal will undermine the inviolability of all
human life. 7'
Approaching the issue of stem cell research with a complete
understanding of the Church's teaching on the sanctity of life makes the
analysis of each proposal clearer. 72 Embryonic stem cell research cannot
be conducted without embryos,'73 and in the eyes of the Church, embryos
are human beings that deserve the same amount of respect as all other
people.' 74 Therefore, any research that destroys embryos, no matter how
noble the final result or intent of the research, is denounced and
unsupported by the Catholic Church.'75 The most efficacious means of
evaluating these three proposals through the lens of Catholic teaching is
to determine the necessity of ESC research and then evaluate the
possible effects of each individual proposal. 76
B. Is Embryonic Stem Cell Research Necessary?
"Stem cell research" is an all-encompassing term that refers to
numerous types of stem cell research and, contrary to popular belief, not
171. See Evangelium Vitae, supra note 17, 95.1 (stating that in the "present social
context, marked by a dramatic struggle between the 'culture of life' and the 'culture of
death,' there is need to develop a deep critical sense, capable of discerning true values and
authentic needs"); see also Ephesians 5:8-11 ("Live as children of light for light produces
every kind of goodness and righteousness and truth. Try to learn what is pleasing to the
Lord. Take no part in the fruitless works of darkness; rather expose them.").
172. See, e.g., MAY, supra note 117, at 19-46 (beginning his book on Catholic bioethics
by dedicating the first chapter to a summary of the Church's teaching on bioethical issues
so that the reader may better understand the foundation of the ethical issues raised in
subsequent chapters).
173. Contra Gautam Naik & Antonio Regalado, Scientists Seek Methods To Create
Stem Cells Without Using Embryos, WALL, ST. J., Aug. 3, 2001, at B1 (reporting on
Infigen, Inc.'s attempt to obviate ethical concerns by creating ESCs without using embryos
through a process known as "cellular reprogramming," where adult cells from a particular
patient are "brought back to their embryo-like state"). Cf. Weiss, supra note 61
(announcing the intent of ACF to create "embryo-like entities" that are "fatally flawed"
such that they could never develop into persons because of scientifically generated lethal
mutations).
174. See CATECHISM, supra note 2, 2323 ("Because it should be treated as a person
from conception, the embryo must be defended in its integrity, cared for, and healed like
every other human being.").
175. See Humanae Vitae, supra note 1 (explaining that a good intent that ends in an
evil act or an evil intent that ends in a good act is still evil); see also CATECHISM, supra
note 2, T 2274.
176. We stand at a precarious point in history where our scientific decision now could
have serious ethical implications later. See July 2001 Hearings, supra note 5 (testimony of
Richard M. Doerflinger, Associate Director for Policy Development at the Secretariat for
Pro-Life Activities).
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just ESC research.': To date, the use of ESCs, as opposed to stem cells
obtained from adult, umbilical, placental, or natural abortions, has not
proven successful in treating human disease.' Although many scientists,
researchers, and patients boast of the promise that ESCs hold for
treating disease,179 ESCs pose a problem that has been largely ignored -
histocompatibthty.'
Histocompatibility is most commonly encountered in organ
transplantation but is also a concern when treating individuals with
ESCs.' Histocompatibility antigens (HLA) are attached to all human
177. See EXECUTIVE SUMMARY, supra note 31, at 1 (defining stem cells as those that
are "capable of continually reproducing themselves" and describing the embryonic stem
cells as "the most fundamental and extraordinary of the stem cells"); see also Reality
Check #2, supra note 12 (warning individuals that "'[s]tem cell research' refers to research
using various types of stem cells" and illuminating the fact that seventy percent of
Americans disagree with government funding of "stem cell research which requires
destroying human embryos").
178. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(describing the recent advances in adult stem cell research and the disappointments in
ESC research); see also Reality Check #1, supra note 101 (discrediting the belief that ESCs
are better than other stem cells for treating disease and noting that adult stem cells have
already helped hundreds of thousands of patients while ESCs "have not helped a single
human patient").
179. See Rick Weiss, Nobel Laureates Back Stem Cell Research: Group of 80 Recipients
Sends Letter Asking Bush Not To Block U.S. Funding for Studies, WASH. POST, Feb. 22,
2001, at A2 (reporting that "organizers believe [the letter to Bush backing ESC research]
is the biggest collection of Nobel signatures ever sent to a president"); see also Laurie
McGinley, Influential GOP Sen. Frist Supports Stem-Cell Research, WALL ST. J., July 18,
2001, at A20 (announcing that the doctor, Senator, and presidential advisor, once silent on
the stem cell research issue, decided to back ESC research because of its "huge potential
for improving health"); Laurie McGinley, Nancy Reagan Urges GOP To Back Stem-Cell
Studies, WALL ST. J., July 12, 2001, at B2 (reporting that Former First Lady Nancy
Reagan, whose husband suffers from Alzheimer's, favors federal funding for ESC
research); Connie Mack, I'm Pro-Life and in Favor of Stem Cell Research, WALL ST. J.,
June 19, 2001, at A22 (describing her arguably hypocritical role as a former Senator, pro-
life Catholic, and cancer survivor in support of ESC research). For the Pope's response to
individuals like Connie Mack, see Evangelium Vitae, supra note 17, 95.3 (addressing his
concern about the pluralistic society in which we live by stating that "[t]oo often it
happens that believers, even those who take an active part in the life of the Church, end
up by separating their Christian faith from its ethical requirements concerning life, and
thus fall into moral subjectivism and certain objectionable ways of acting").
180. See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (testifying to the
House that "embryonic stem cells face the very real possibility of immune rejection, while
use of a patient's own adult stem cells is free from this problem").
181. Histocompatibility is defined as the degree to which one's human leukocyte
antigens (HLA or histocompatibility antigens) match the HLAs of a transplanted organ,
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cells, including ESCs, and they recognize friendly and foreign cells in the
body.' 82 Hence, if a foreign cell enters the body, the HLAs recognize it
and activate the immune system to destroy it.' Matching an individual's
HLAs to a foreign cell's HLAs is a difficult task because each
individual's HLA proteins located on the five separate HLA loci must
match.' Therefore, if an individual's body is treated with embryonic
stem cells that have significantly different genetic codes, the recipient's
body will not recognize the cell and will reject it.1 Thus, any treatments
developed from cells significantly different from the potential patient's
own will not succeed in treating disease without the possibility of lifetime
use of toxic immunosuppressive drugs."" There are, however, two ways
around the histocompatibility problem: (1) to engage in SCNT for
bone marrow, or blood. See Amy B. Hahn, Ph.D., Histocompatibility and Immunogenetics
Terminology, at www.ashi-hla.org/aboutfiles/about-h&i-terminology.html (last visited
Mar. 5, 2003); see also Sept. 2000 Hearings, supra note 104 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (describing the
possible rejection of tissues derived from ESCs, as is the case with other organ
transplants).
182. See Finding the Perfect Donor, BLOOD & MARROW TRANSPLANT NEWSLETTER
(Blood and Marrow Information Network), May 2001, at www.bmtinfonet.org/newsletters/
issue53/perfectdonor.html (last visited Nov. 12, 2001) (analogizing HLAs to a cellular
fingerprint in that they identify cells as either belonging to our body or not).
183. See id.
184. Each cell has five different HLA proteins on its surface that are created from a
section of one's chromosome called an allele. Id. The five loci of the alleles are called
HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1, and each codes for a different
protein that, in the case of certain organ transplants, must match significantly, or the organ
will be rejected. See id. (admitting that finding a donor that is a "perfect match" is
extremely difficult, yet important to transplant patients and stem cell patients alike).
185. See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (revealing that
ESCs face the possibility of immune rejection and have been proven ineffective in animal
studies).
186. Sept. 2000 Hearings, supra note 104 (testimony of Dr. David A. Prentice, Ph.D.,
Professor of Life Sciences, Indiana State University; Adjunct Professor of Medical and
Molecular Genetics, Indiana University School of Medicine; Founding Member, Do No
Harm: The Coalition of Americans for Research Ethics) (distinguishing the use of adult
stem cells from ESCs because ESCs "will face transplant rejection, as would any normal
organ transplant, and require use of toxic immunosuppressive drugs, perhaps for the
lifetime of the patient," whereas adult stem cells do not face that problem).
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therapeutic cloning purposes; 8 or (2) to use cells compatible with one's
own body, i.e., adult, umbilical, or placental stem cells."'
The former solution is controversial because it is a form of cloning that
requires - as a prerequisite to successful treatment - the ability to create,
raise, and harvest human embryos.' 89 The need for therapeutic cloning
arises from the possible rejection of ESCs by the patient's body.1 o If
scientists use SCNT to transfer a patient's own genetic material to an
embryo, however, they can create an embryonic clone of the patient and
eliminate the histocompatibility problem.9 ' Although none of the
proposals specifically promote SCNT and therapeutic cloning, the use of
embryos for ESC research is the first step toward this process because
187. See Rick Weiss, Firm Aims To Clone Embryos for Stem Cells, WASH. POST, July
12, 2001, at Al. Advanced Cell Technologies began work on cloning embryos because
"the presumption, held by many scientists, [is] that the best way to create stem cells for
therapeutic purposes may be to custom-produce batches of them for individual patients
through cloning. That way the cells will be genetically identical to the patient and will not
be rejected as foreign." Id.; see also July 2001 Criminal Justice Hearings, supra note 9
(testimony of Dr. David A. Prentice, Ph.D., Professor of Life Sciences, Indiana State
University; Adjunct Professor of Medical and Molecular Genetics, Indiana University
School of Medicine; Founding Member, Do No Harm: The Coalition of Americans for
Research Ethics) (voicing the opinion of some that "human cloning might be necessary if
embryonic stem cells could ever have clinical application to human beings").
188. See Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 2 (2001);
see also Bush Proposal, supra note 5 (informing the public that "stem cells can be derived
from sources other than embryos - from adult cells, from umbilical cords ... [and] from
human placenta" and stating that "research on these type of stem cells is also promising");
NBAC REPORT AND RECOMMENDATIONS, supra note 12, at 12-14 (describing types of
adult stem cells found in the body and their potential for use in disease treatment); Rick
Weiss, Fetal Cell Research Funds Are at Risk; Scientists Fear Curbs Over Abortion, WASH.
POST, Jan. 26, 2001, at A3 (stating that "[r]ecent studies suggest that adult stem cells have
great therapeutic potential").
189. See Antonio Regalado, Ethicists, Bodyguards Monitor Scientists' Effort To Create
Copy of Human Embryo, WALL ST. J., July 13, 2001, at B1 (describing the technique
called therapeutic cloning as "hotly debated" and something many consider "unthinkable"
while reporting that one scientific advisor was concerned about "widespread societal
opposition to creating embryos specifically for research").
190. See id. (claiming that ACT clones embryos so that "the cells will be genetically
identical to the patient and will not be rejected as foreign").
191. See id. (describing therapeutic cloning as a means of creating an "embryonic
twin" that would "be a regenerative fountain of youth"). "It contains stem cells that share
the individual's genetic makeup and someday be grown into a wide variety of precisely
matched tissues." Id.; see also July 2001 Hearings, supra note 5 (testimony of Michael D.
West, Ph.D., President and CEO of ACT, Inc., Inc.) (testifying that the solution to the
"problem of histocompatibility would be to create human [ESCs] genetically identical to
the patient ... obtained through the procedure of [SCNT], otherwise known as cloning
technology").
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therapeutic cloning is simply a personalization of stem cell therapy.'12
Scientifically, this is a perfect solution to the histocompatibility
problem,'93 but it raises concerns among the public, not only because it is
a form of cloning, but also because it may lead to the creation, raising,
and harvesting of embryos for therapeutic purposes.'94
The alternative to therapeutic cloning, which also obviates the
histocompatibility problem, is the use of stem cells derived from adult
tissue, 95 umbilical cord blood" and placentas.' 97 These are proven and
successful forms of research without ethical fault, largely because they do
not involve the destruction of embryos. '98 The only argument proffered
against adult stem cell research is that it does not offer the same level of
promise as ESC research.' 99 Some scientists assume an adult stem cell
192. See July 2001 Hearings, supra note 5 (testimony of Michael D. West, Ph.D.,
President and CEO of ACT, Inc.) (explaining the promise of SCNT to create a
personalized "embryo genetically identical to the patient that could. . . 'rejuvenate' an
aged cell... [and] improve the quality of life" for many individuals); see also Weiss, supra
note 187 (claiming that "[tihe idea is to fuse a single cell from an adult (in the future, the
patient) with a donated human egg that has had its own genes removed, to make what is
essentially an embryo" identical to that of the patient); Regalado, supra note 189 (claiming
that "[b]y combining an adult's cell - usually skin, but any cell will do - with an
unfertilized human egg... they can create an embryonic twin of any person").
193. See Weiss, supra note 187 (explaining that many scientists believe the best way to
create stem cells for therapeutic purposes is to have them custom made for each
individual).
194. See Hearing on Human Cloning Before the Senate Commerce Subcomm. on
Science, Technology and Space, 107th Cong. (2001) [hereinafter May 2001 Cloning
Hearings] (testimony of Richard M. Doerflinger, Associate Director for Policy
Development at the Secretariat for Pro-Life Activities). Implementing therapeutic
cloning "would not be a case [where] human embryos are destroyed once to form a
permanent cell line .... For each individual patient, countless human embryos - the
patient's genetic twin brothers and sisters - would have to be created ... then destroyed
for their stem cells." Id. Cf. Regalado, supra note 189 (noting that therapeutic cloning is
ethically questionable because it creates embryos for research and may "lead to the birth
of cloned human[s]").
195. See Laura Johannes, New Findings Point To Huge Potential of Adult Stem Cells,
WALL ST. J., Aug. 13, 2001, at B4 (proposing that if recent adult stem cell studies are true,
adult stem cells could be a viable alternative to the ethically troublesome ESCs and would
not be rejected by a patient's body).
196. See Brown, supra note 155 (reporting on the banking of umbilical cord blood for
its stem cells, which would allow for stem cell treatment of certain diseases).
197. See id. (mentioning that placentas have similar therapeutic promise, if banked
after birth).
198. See Dr. David A. Prentice, Stem Cell Research Alternative, WALL ST. J., June 20,
2001, at A19 (positing that adult stem cell research is a more successful and morally
acceptable approach than'the use of ESCs).
199. Contra July 2001 Hearings, supra note 5 (testimony of Dr. David A. Prentice,
Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of Medical
and Molecular Genetics, Indiana University School of Medicine; Founding Member, Do
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will not be able to treat all of the diseases ESCs potentially could treat
simply because adult stem cells are further along in their differentiation
process." However, recent scientific advances have proven the
opposite2'
Researchers have recently isolated stem cells from fat cells, 202 bone
marrow,20 3 nerve tissue, umbilical cord blood, and other sources.2 5
Moreover, from this isolation process, scientists have taken the first steps
in developing treatments for numerous diseases.2 For instance, adult
bone marrow stem cells have been coaxed into nerve cells in hopes of
treating numerous neurological diseases, such as Parkinson's,
Alzheimer's, and spinal cord injuries.2°7 Likewise, researchers working
with stem cells from human fat cells have created cartilage, muscle, and
bone cells, which advance the promise of growing various replacement
tissues without the use of embryos.2l Unlike the use of therapeutic
No Harm: The Coalition of Americans for Research Ethics). Dr. Prentice believes that
the medical potential of adult stem cells is enormous and has stated that researchers
continue to discover adult stem cell types for more forms of tissue. Id. In addition,
according to Dr. Prentice, other research suggests that adult stem cells will be able to
transform into all tissue and cell types. Id.
200. See Johannes, supra note 103 (reporting in 1999 that adult stem cells could not
become any form of tissue other than that from which those cells came). Cf. Johannes,
supra note 195 (reporting in August 2001 that adult stem cells could morph into many of
the body's tissues).
201. July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger, Associate
Director for Policy Development at the Secretariat for Pro-Life Activities) (testifying that
advances in "tissue engineering" using adult stem cells have allowed researchers to rebuild
ears, tracheas, and hearts and also listing the numerous diseases adult stem cells were
successful in treating).
202. See Weiss, supra note 103 (announcing the successful isolation of fat stem cells
that were grown into a variety of tissue types).
203. See id. (describing the transformation of bone marrow stem cells into nerve cells
as the "latest in a string of recent advances adding credence to the novel idea that human
cells can change their identities late in life").
204. See Terence Chea, Stalking Neural Stem Cells; Md. Firm's Work May Aid Brain
Treatment, WASH. POST, Oct. 13, 2000, at E5 (discussing the isolation of neural stem cells
that could offer treatment for some devastating diseases by replacing damaged cells with
healthy ones).
205. See Brown, supra note 155 (reporting on the possibilities of treatments from
umbilical cord blood and placentas).
206. July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (testifying that
adult and other postnatal stem cells have the potential to cure diabetes, Parkinson's, heart
disease, Alzheimer's, and other degenerative diseases for which ESCs are sought).
207. Weiss, supra note 103.
208. Id.
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cloning to negate the histocompatibility problem, these alternative stem
cells have been successfully used to treat human beings."" These
advances force the ethical question of whether using ESCs for research is
210
even necessary.
C. The Broader the Better?
According to Senator Specter and his supporters, ESC research is
absolutely necessary to improve the lives of those who suffer from
numerous diseases and injuries. 1 Of the three proposals, the Specter
Bill allows for the greatest amount of stem cell research by supporting
research on leftover embryos obtained from IVF clinics. 2 2 However, a
bill this broad is not necessarily the best or most responsible means of
researching the therapeutic possibilities of stem cells because adult and
other forms of stem cells have proven just as, if not more, effective in
treating disease.1 3
209. July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (testifying about
the "impressive volume of scientific literature" attesting to the use of adult stem cells to
successfully treat patients with many of the diseases ESCs "only prospectively promise to
treat" and stating that "[alnimal research strongly suggests that more therapeutic
applications of adult stem cell research will follow").
210. See Prentice, supra note 198 (claiming that "more and more researchers have said
that embryonic stem cells may not be needed after all for medical progress"); see also July
2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger, Associate Director for
Policy Development at the Secretariat for Pro-Life Activities) (warning that the rising
scientific proof of complications with ESCs and the increasing promise and success of
adult stem cells has allegedly caused the withholding of information by some researchers
regarding the problems with ESCs under the guise that the information is too "politically
sensitive").
211. July 2001 Hearings, supra note 5 (statement of Tom Harkin (D-IA)) (stating that
he and Senator Specter sponsored their bill in order to find cures for and save the lives of
those who are suffering from numerous debilitating diseases). Note that these
"debilitating diseases" that Senators Harkin and Specter want to treat include diseases like
diabetes, heart disease, Parkinson's, and spinal cord injuries, all of which have been
treated or are showing great promise of treatment with adult and other post-natal stem
cells. See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics).
212. Compare Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001), with
Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 2(b) (2001), and Bush
Proposal, supra note 5.
213. See Current Clinical Use, supra note 103 (providing a list of successful uses of
adult stem cells to treat human patients and explaining that ESCs have no success in
treating human patients). But see David Baltimore, Don't Impede Medical Progress,
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The Specter Bill claims that ESCs may be derived from donated
human embryos leftover from IVF treatments, provided that specific
conditions are met.1  Thus, the Specter Bill allows for an unlimited
number of embryos to be destroyed in research funded by federal
dollars, so long as they meet certain requirements and are not purchased
with federal monies.215  From a purely scientific standpoint, this bill
allows for the optimum amount of scientific inquiry; however, when
viewed from the Catholic perspective, it is abhorrent to the sanctity of
life.
216
Using human embryos to conduct research contradicts the very
foundation of the Gospel of Life, as well as some basic codes of medical
ethics.217 As previously discussed, for the Church, life begins at the
moment of conception, regardless of when, where, or why the life is
conceived. The Church did not arbitrarily choose this moment in time;
rather, it developed from Sacred Scripture and Apostolic Tradition.218 At
conception, a person is "willed for its own sake in the image and likeness
of the living and holy God."" 9 According to the Bible, human beings are
WALL ST. J., July 30, 2001, at A18 (explaining that banning all research on these
"miraculous cells" would severely impede science's "wholly new way" of treating disease).
214. See Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001).
215. See id.; see also July 2001 Hearings, supra note 5 (testimony of Richard M.
Doerflinger, Associate Director for Policy Development at the Secretariat for Pro-Life
Activities) (quoting Dr. John Gearhart as admitting that "[y]ou may have to establish
hundreds of lines [of ESCs] to get the few you'd want to have," which means that
thousands of human embryos would be required to establish hundreds of lines, especially
if the original cell lines become too unstable for further use).
216. See Evangelium Vitae, supra note 17, 57.3 (reiterating the moral illicitness of
taking innocent human life, especially at its earliest stages).
217. See Donum Vitae, supra note 30, at Intro.
Human life is sacred because from its beginning it involves 'the creative action of
God' and it remains forever in a special relationship with the Creator, who is its
sole end. God alone is the Lord of life from its beginning until its end: no one
can, in any circumstance, claim for himself the right to destroy directly an
innocent human being.
Id.; see also July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (testifying to the
ethical impropriety of destroying one human life for the possible benefit of another
because this would violate "the basic tenet of the healing arts: 'first do no harm').
218. See John Paul II, Apostolic Constitution Fidei Depositum, in CATECHISM, supra
note 2, at 5 (explaining that the Catechism is a "statement of the Church's faith and of
Catholic doctrine, attested to or illuminated by Sacred Scripture, the Apostolic Tradition,
and the Church's Magisterium").
219. CATECHISM, supra note 2, $ 2319.
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made in the image and likeness of God. 20 Thus, humans deserve respect
from the moment of their creation at conception."' The human embryo,
then, is a human person deserving of the protection, healing, and respect
attributed to all people."' The Specter Bill does not respect these values
because it promotes the destruction of human embryos to glean ESCs for
research.2
Moreover, one must inquire into the possible repercussions if the
Specter Bill were enacted.2A The Specter Bill only funds research using
ESCs from leftover IVF embryos, yet this could be the first step down a
path toward therapeutic cloning.2 ' So far no ESCs have successfully
treated any human beings.26 Even though private research continues,
the possibility for clinical treatment is unlikely due to the problem of
histocompatibility.27  Therefore, the next step would be personalized
220. See Genesis 1:26,27 ("God said: 'Let us make man in our image, after our likeness.
.'God created man in his image; in the divine image he created him; male and female he
created them.").
221. CATECHISM, supra note 2, T 2319.
222 Id. T 2323.
223. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(stating that the use of embryos for research purposes, regardless of their origin, "violates
a central tenet of all civilized codes on human experimentation beginning with the
Nuremberg Code: [i]t approves doing deadly harm to a member of the human species
solely for the sake of potential benefit to others").
224. Following Pope John Paul If's call to be promoters of the Gospel of Life, we must
evaluate issues threatening life from all angles, including the future repercussions. See
SEIFERT ET AL., supra note 125, at 107 (asking readers of Evangelium Vitae to question
themselves as to how they, and their politicians, can promote the Gospel of Life through
their roles in society, their actions, and their support for certain public policy).
225. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(testifying on the slippery slope of allowing some federal funding of ESC research now
and what that will lead to in the future). This first step toward therapuetic cloning is
foreshadowed by the NBAC's fourth recommendation in which it concludes that "at this
time, federal funding should not be provided to derive [ESCs] from [SCNT]. Nevertheless,
scientific progress and the medical utility of this line of research should be monitored
closely." See EXECUTIVE SUMMARY, supra note 31, at 6 (emphasis added).
226. See Current Clinical Use, supra note 103 (reporting that there are no current uses
of ESCs to aid, improve, or cure anyone with any of the diseases that ESCs may
potentially treat).
227. See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (stating the
substantial risk of immune rejection by the body, or the transplanted cells attacking the
host, or even the formation of a tumor).
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stem cell treatments or the use of SCNT to clone patients to create
embryonic twins from which ESCs can be harvested.m
Presently, many individuals cringe at the thought of scientific
treatment involving cloning and do not imagine that ESC research will
lead to such an abominable act. 29 However, if the public's and patients'
hopes are raised by ESC research only to be let down by the realization
of the histocompatibility problem, would therapeutic cloning still be
viewed in the same negative context as it is today? 23°
Private sector researchers working with cloned embryos have become
somewhat immune to the shock the general public experiences when
cloning is discussed.23 Will not the same desensitization occur once ESC
research has been the common practice for three, five, or ten years?232
All it would require to amend the Specter Bill to allow therapeutic
cloning is the same groundswell of popular support that originally
brought ESC research to the forefront of the social, political, and ethical
debate.23' Regardless of what may happen in the future, the Specter Bill
22& July 2001 Hearings, supra note 5 (testimony of Michael D. West, Ph.D., President
and CEO of ACT, Inc.) (explaining that because ESCs come from another individual they
are subject to histocompatibility problems, but further explaining that the most promising
solution is therapeutic cloning because it results in an exact genetic match).
229. See Allen, supra note 18 (reporting that the cloning of the sheep, Dolly, in 1997
felt instinctively wrong and referring to the uncomfortable "gut reaction,". "yuck factor,"
or "wisdom of repugnance" it created); see also July 2001 Hearings, supra note 5
(testimony of Richard M. Doerflinger, Associate Director for Policy Development at the
Secretariat for Pro-Life Activities) (claiming that although therapeutic cloning was
supported by the NIH in the past, it was widely condemned nationwide, even by abortion
supporters); Rick Weiss, Scientists Declare Progress on Human Cloning, WASH. POST,
Aug. 8, 2001, at A2 (reporting that when three "maverick" scientists, who are attempting
to clone a human being, testified in front of an independent panel of scientists on their
progress, they were ridiculed by their colleagues); May 2001 Cloning Hearings, supra note
194 (testimony of Richard M. Doerflinger, Associate Director for Policy Development at
the Secretariat for Pro-Life Activities) (stating that due to the lack of success in cloning
procedures, therapeutic cloning has fallen out of favor with scientists, and emphasizing the
moral and ethical complications of cloning).
230. See July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
("Once our consciences are numbed to the moral wrong of using so-called 'spare' human
embryos for research, our society will move on to even more egregious abuses.").
231. Id. (testifying that groups like the American Society for Reproductive Medicine,
which have conducted research on embryos, have been deadened to the sensitive ethical
topic of using embryos in research and actually justify their research as morally superior).
232 Id. (proposing that "[i]f the federal government funds even a limited amount of
research that relies on destroying human embryos, this deadening of consciences will
occur on a wider scale and with government approval").
233. Daniel Perry, Patients' Voices: The Powerful Sound in the Stem Cell Debate,
WASH. POST, Mar. 1, 2000, at A16 (opining that in the political dispute over the new
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still offends the very sanctity of life in which Catholics believe, and if
enacted, the bill would further serve as an affront to those beliefs.
TM
D. Middle Ground, Unstable Ground
President Bush's proposal for the federal funding of ESC research is
somewhat narrower than that of the Specter Bill because it allows for
research only on those cell lines already derived from embryos.23'
President Bush wanted to use only those ESC lines "where the life or
death decision ha[d] already been made." 6  Technically, no taxpayer
dollars are used to destroy embryos, but the proposal still exploits human
life at its most vulnerable stage by using taxpayer money to acquire and
conduct research upon ESC lines derived from the destruction of
embryos3 7
Even though the life and death decision has already been made, using
those cell lines implies that the destruction of embryos is acceptable,
even though it is not. 38 Although it was not necessarily President Bush's
intention, the proposal also sets the stage for the continued destruction
of embryos for research purposes. 39  Almost immediately after the
President's announcement, proponents of broad federal funding for ESC
research attacked the availability, quantity, and quality of the stem cell
lines.2'0 These researchers argued that - at best - the Bush proposal
research, patients have played a critical role in courting public approval by placing a face
on the promise of biomedical research).
234. Donum Vitae, supra note 30, at pt. 1, $ 1 ("Life once conceived, must be protected
with the utmost care.").
235. Compare Bush Proposal, supra note 5 (restricting research to currently existing
cell lines), with Stem Cell Research Act of 2001, S. 723, 107th Cong. § 2 (2001) (limiting
ESC research to those embryos donated in excess of IVF need).
236. Bush Proposal, supra note 5.
237. See United States Conference of Catholic Bishops, President Bush's Stem Cell
Decision, available at http://www.nccbuscc.org/prolife/issues/bioethic/fact801.htm (last
visited Sept. 26, 2001) [hereinafter Bush's Stem Cell Decision] (explaining that the pre-
existence of the cell lines does not exempt their use from moral critique).
238. See Donum Vitae, supra note 30, at Pt. 1, $1 5 (claiming that "it is immoral to
produce human embryos destined to be exploited as disposable 'biological material.' and
condemning the acquisition of embryos for the sole purpose of research as a usurpation of
God's position as judge of life and death).
239. Compare Bush Proposal, supra note 5 (explaining the President's desire to limit
ESC research to a specific number of cell lines), with Bush's Stem Cell Decision, supra
note 237 (suggesting that researchers created additional stem cell lines in anticipation of
President Bush's proposal and that "[s]cientists will undoubtedly continue to kill
additional embryos with private funds, and if the first set of 60 proves inadequate they will
recommend these new cell lines for use in federally funded research").
240. See Harold Varmus & Douglas Melton, The Stem-Cell Compromise..., WALL
ST. J., Aug. 14, 2001, at A14 (questioning whether the sixty cell lines even exist, then
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would allow for some of the necessary preliminary research but would
need to be amended to treat the population adequately.2 41 Conversely, if
all did not go well, the President's moral and political balance would be
thrown off by patients and scientists who would vigorously challenge the
President's proposal.242 Such a strong lobby would only serve to push the
administration closer to allowing embryos for federally funded research
and eventually to the possibility of therapeutic cloning. 243
In the long run, the Bush proposal would only delay the movement
toward the use of embryos in research, not halt it24 Not only will Bush's
limited research continue to face objections from the world of science,245
but it allows the problem of histocompatibility to remain. Z 6 As much as
President Bush may be trying to protect human life, his proposal fails to
exemplify the respect for life to which Pope John Paul II calls all people
of good will.247
questioning whether sixty cell lines will be enough, and finally questioning whether the
sixty cell lines are of research quality); see also Ceci Connolly & Rick Weiss, Stem Cell
Colonies' Viability Unproven; Some in NIH List of 64 Termed Young, Fragile, WASH.
POST, Aug. 28, 2001, at Al (reporting that at least one-third of the stem cell lines allowed
by the Bush proposal for research are young and fragile and possibly unable to be used in
ESC research); Antonio Relegado et al., What Access Will Researchers Have to the 60 Cell
Lines? And Do They Even Exist?, WALL ST. J., Aug 13, 2001, at B1 (quoting Doug
Melton, who doubts that companies are going to simply hand over their stem cell lines to
researchers).
241. Varmus & Melton, supra note 240 (positing that the sixty cell lines will be
adequate to conduct the experimental work only if certain criteria are met and questioning
whether the approved lines will be enough).
242 Id.
243. See Gibbs & Duffy, supra note 165, at 16 (noting that Bush opened the door to
research on ESCs derived from embryos and predicting that pressure to expand the
research will be intense, making it "harder to draw a bright line against cells harvested in
the future").
244. Id. (describing the strong objections from scientists who will no doubt continue to
lobby for the broadest possible research).
245. See Varmus & Melton, supra note 240 (voicing the objections of scientists and
pointing out that the political balance Bush tried to find will "certainly be vigorously
challenged by the legitimate demands of patient advocacy groups, federally funded
scientists, and many others who want a better shot at success").
246. For a discussion of the histocompatibility problem, see Part IV.B. See also July
2001 Hearings, supra note 5 (testimony of Michael D. West, Ph.D., President and CEO of
ACT, Inc.) (testifying that as promising as ESCs may be, they do not solve the remaining
problem of histocompatibility).
247. See Evangelium Vitae, supra note 17, 29.3. See generally United States
Conference of Catholic Bishops, Living the Gospel of Life: A Challenge to American
Catholics, at www.nccbuscc.org/prolife/gospel.htm (last visited Sept. 2, 2001) [hereinafter
Living the Gospel of Life] (calling Catholics to fulfill their duties as teachers and pastors in
proclaiming the Gospel of Life).
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E. Being Responsible About Stem Cell Research
Unlike the proposals of Senator Specter and President Bush, the
Responsible Stem Cell Research Act of 2001 allows for research only on
specific types of stem cells that have proven effective in treating disease,
such as adult, umbilical cord, placenta, and spontaneous abortion stem
cells. 24 These forms of stem cells have not only demonstrated successful
laboratory usage, but in some cases, they have been used on human
subjects with promising results. 49 Additionally, stem cells derived from a
patient's own body completely avoid the histocompatibility problem.250
These stem cells are morally acceptable because they do not require the
destruction of any form of human lifej 5'
The use of adult stem cells, derived from one's own tissue, has been
attacked by proponents of ESC research as not having the ability to
differentiate as successfully as ESCs and therefore unable to treat as
248. See Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 3(b)
(2001); see also July 2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger,
Associate Director for Policy Development at the Secretariat for Pro-Life Activities)
(positing that in the two years since his testimony before the same subcommittee, there
were "startling advances" in research with adult and other non-embryonic stem cells that
not only offer a viable alternative to ESC research, but an alternative that is clinically
proven to be effective).
249. See Sept. 2000 Hearings, supra note 104 (testimony of Dr. David A. Prentice,
Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of Medical
and Molecular Genetics, Indiana University School of Medicine; Founding Member, Do
No Harm: The Coalition of Americans for Research Ethics) (listing the clinical treatments
for which adult stem cells have been used, including some cancer treatments, multiple
sclerosis, systemic lupus, juvenile rheumatoid arthritis, and bone and cartilage
deformities); Reality Check #1, supra note 101 (describing the effectiveness of adult stem
cells in treating juvenile diabetes, spinal cord injuries, immune deficiency, and corneal
repair).
250. See July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (testifying about
the substantial risk of immune rejection that accompanies the use of ESC). For an in-
depth discussion of adult stem cells and the histocompatibility problem, see Part IV.B.
251. July 2001 Criminal Justice Hearings, supra note 9 (testimony of Dr. David A.
Prentice, Ph.D., Professor of Life Sciences, Indiana State University; Adjunct Professor of
Medical and Molecular Genetics, Indiana University School of Medicine; Founding
Member, Do No Harm: The Coalition of Americans for Research Ethics) (describing
adult stem cell research as a "less morally problematic alternative" to ESC research); July
2001 Hearings, supra note 5 (testimony of Richard M. Doerflinger, Associate Director for
Policy Development at the Secretariat for Pro-Life Activities) (calling the use of
taxpayers' money for the deliberate destruction of embryos immoral, but offering adult
stem cell research as a significantly better alternative).
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many diseases.52  Although this assertion is grounded in what many
scientists thought was fact, researchers have recently found that adult
stem cells from one part of the body, like bone marrow, can develop into
cells of another kind of tissue, like nerve cells, with few complications. 13
Researchers also discovered stem cells for certain types of tissue they
previously thought did not have stem cells5 -" The significance of such
findings is that if adult stem cells exist for all types of tissue, or if certain
adult stem cells can morph into other tissue, then the argument that
ESCs can develop into all types of the body's cells is moot 5 Moreover,
adult stem cells' success rate in treating humans is significantly higher.26
Within the past two years, adult stem cells have successfully treated
individuals suffering from Type I juvenile diabetes, spinal cord injuries,
children born without immune systems, and legally blind individuals. 57
The Ensign Bill stimulates this type of research by increasing the
budget for adult, umbilical cord, and placental stem cell research to $275
million.5 8 It does more than allocate funds because it also establishes a
donor bank for qualifying human stem cells, which can be used for
research and therapeutic purposes."9 Ideally, the nationwide donor bank
252. See NIH Fact Sheet on Human Pluripotent Stem Cell Research Guidelines,
available at http://www.nih.gov/news/stemcell/stemfactsheet.htm (last visited Sept. 2, 2001)
(admitting that although adult stem cells have proven to be more "plastic" than once
thought, in comparison to ESCs, they have limited potential); see also NBAC REPORT
AND RECOMMENDATIONS, supra note 12, at 7 (highlighting the fact that adult stem cells
are more differentiated than ESCs and cannot develop into any cell type like the ESCs);
July 2001 Hearings, supra note 5 (statement of Senator Tom Harkin (D-IA)) (disagreeing
with the proposition that using adult stem cells for research is all that is necessary). But
see Johannes, supra note 195 (asserting that "stem cells found in adults have an incredible
ability to morph into many types of tissues").
253. See Weiss, supra note 103 (reporting the successful transformation of bone
marrow stem cells into neural tissue cells).
254. Id. (reporting on recent advances in science that suggest many parts of the body
contain stem cells).
255. See id. (stating that resorting to the use of embryonic stem cells may not be
necessary if replacement tissues can be grown with adult stem cells); July 2001 Criminal
Justice Hearings, supra note 9 (testimony of Dr. David A. Prentice, Ph.D., Professor of
Life Sciences, Indiana State University; Adjunct Professor of Medical and Molecular
Genetics, Indiana University School of Medicine; Founding Member, Do No Harm: The
Coalition of Americans for Research Ethics) (testifying that "human embryonic stem cell
research is illegal, unethical, and unnecessary").
256. See Reality Check #1, supra note 101.
257. Id.
25& See Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 4(b)
(2001).
259. Id. § 3(a). A stem cell donor bank would allow individuals to donate ethically
acceptable stem cells to a nationwide registry so that a diverse base of stem cells would be
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would allow individuals to donate adult stem cells, umbilical cord blood,
and placental stem cells to a public reserve like that of the national bone
marrow registry7m With proper implementation of the patient registry, 1
the donor bank would be able to locate qualifying stem cells that are a
substantial genetic match so that any patient could be treated quickly and
effectively.
262
For those who promote the Gospel of Life, the most important aspect
of the Ensign Bill is its recognition of the sanctity of human life at its
weakest stages because it funds stem cell research that does not involve
the destruction of embryos. 3 It also advocates the proven and necessary
research that shows promise in treating disease2 6 Instead of having to
endure a path fraught with the possibility of political debate over the
creation of embryos for research, using stem cells other than ESCs is a
method of treatment that is ethically acceptable and highly successful.2 5
V. CONCLUSION
For the most part, people make decisions based upon their best
intentions and what they deem best for themselves, their family, others,
or society in general. Therefore, many political arguments are couched
in the language of doing what is best for one's constituency or the nation
as a whole.266 Unfortunately, this can make it difficult to determine what
is at the root of an issue. Drawing on Catholic doctrine and Apostolic
available to treat numerous patients. See Brown, supra note 155, for an example of such a
donor bank, albeit privately run, with respect to umbilical cord blood.
260. See Finding the Perfect Donor, supra note 182 (describing how to find a bone
marrow donor using the registry).
261. See Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 3(d)-(e)
(2001).
262 See Brown, supra note 155; see also Finding the Perfect Donor, supra note 182.
263. See Responsible Stem Cell Research Act of 2001, S. 1349, 107th Cong. § 3(b)
(2001); see Living the Gospel of Life, supra note 247, 28-29 (challenging all Christians
involved in public life, including politicians, to promote virtues like the Gospel of Life and
to "explain, persuade, correct and admonish those in leadership positions who contradict
the Gospel of [L]ife through their actions and policies").
264. Responsible Stem Cell Research Act of 2001, S. 1349,107th Cong. § 2(9) (2001).
265. See United States Conference of Catholic Bishops, Scientific Experts Agree:
Embryonic Stem Cells Are Unnecessary for Medical Progress, available at http://
nccbuscc.org/prolife/issues/bioethic/fact40l.htm (last visited Sept. 2, 2001) (quoting
numerous scientists involved in the field of stem cell research who believe adult stem cells
- not ESCs - to be the proper means of treating the diseases).
266. For an interesting comment on political leaders making political decisions based
upon their personal interests, see Sarah Lueck, Feeling the Pain: When Lawmakers Have a
Personal Stake in a Health Issue, Partisanship Can Fade Quickly, WALL. ST. J., Feb. 21,
2001, at R6.
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Tradition, Pope John Paul II's Evangelium Vitae reiterates the
inviolability of human life at all stages from conception until natural
death.2 67 Applying this tenet to the proposed forms of stem cell research
facing Congress, there is only one bill that is clearly in accord with the
Gospel of Life: the Responsible Stem Cell Research Act of 2001.
For Catholics, the focus of the stem cell research debate is not
biological utilitarianism, but the protection of life at its weakest stages.
Catholics begin with an understanding of life that is unshakeable and
must be upheld, for if it is not, arbitrary and utilitarian means of defining
when life begins will dominate. The ultimate slippery slope argument is
that the use of human embryos for ESC derivation may become the first
step toward the therapeutic cloning of individuals and the creation of
human embryos to harvest spare body parts. Therefore, Catholics and
individuals who believe in the sanctity of human life from its conception
must throw their support, votes, and prayers behind those who promote
similar political and social values. It is not an option, but rather a
fundamental tenet of the Catholic faith: the sanctity of human life.
267. See Evangeliun Vitae, supra note 17, $1 2.2.
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